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A stroke is defined as abnormal brain functionality due to a disruption in the
blood supply produced by a hemorrhage or clot. They can be classified as symp-
tomatic or asymptomatic. In this dissertation I imaged deep into the brains of live
rodents using two-photon excited fluorescence microscopy to study hemorrhagic
asymptomatic strokes. We focused high-energy lasers on the surface of a partic-
ular blood vessel to rupture its endothelium to cause bleeding. The damage was
only confined to the focus of the laser (∼1 µm2). Employing these methods, we
investigated two issues that could advance stroke treatments. First, we evaluated
the use of blood breaking drugs or anticoagulants on the effect of hemorrhage size.
We examined tissue plasminogen activator (tPA), the only FDA approved drug to
dissolve blood clots, and the following anticoagulants: dabigatran etexilate (DE),
warfarin and heparin. We found that DE and tPA treated mice developed hemor-
rhages of comparable size than control mice (treated with saline). In contrast, mice
treated with warfarin and heparin (anticoagulants) developed larger hemorrhages.
It is relevant to characterize the size of brain hemorrhages since it correlates with
patient prognosis. The study suggests that tPA and DE do not exacerbate damage
from hemorrhaging and they present a lower risk for bleeding complications when
compared to warfarin and heparin. In the second part of this dissertation, we
analyzed neuronal activity around microhemorrhages to characterize the resulting
region of damage. We compared calcium transient responses to a peripheral stimu-
lus from cortical neurons and neuropil. We found that calcium transient responses
obtained after a microhemorrhage were inhibited or had smaller amplitudes than
responses obtained before microhemorrhage induction. In addition, the amplitude
of the responses is correlated with the distance from the edge of the hemorrhage.
Furthermore, calcium transient responses improved over four hours after a hem-
orrhage, returning to normal responses (i.e. comparable to control experiments)
one day after initial onset. This dissertation provides a better understanding of
microhemorrhage pathophysiology.
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6.1 Description of experiment. A. Description of the task, following 4 brief prepara-
tory taps over a specified target, the subject executed a last tap where after
making contact with the target, the subject ramped up the vertical force ap-
plied by his finger to a maximum. The figure shows this last tap. The time
of interest was 500 ms before and after contact (red in the time axis). The
subject is wearing a custom thimble during the taps, the thimble allowed a
unique contact point and friction cone for force direction. B. Fingertip force in
the three directions was recorded while performing the task; the figure shows
the vertical force magnitude for one trial 500 ms before and after contact.
C. Fine-wire EMG from the seven muscles of the index finger was recorded
while performing the task. Normalized weighted EMG is obtained after being
filtered, full-wave rectified, normalized (by MVC), weighted (by physiological
cross sectional areas) and smoothed (50 ms symmetric moving average) the
EMG signals. D. The norm weighted EMG for each of the muscles, constitute
a component of the muscle coordination pattern 7D vector (m(t))The coor-
dination pattern alignment is the angle between the m(t) for each interval of
time (-500 ms to 500 ms) and the m(t) at the time when the vertical force
reached its maximum value. E. The best fit that described the evolution of the
coordination pattern alignment during the transition from motion to force is a
sigmoid. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
6.2 Vectorial representation of the coordination pattern. A. Normalized weighted
EMG signals from three muscles and its coordination pattern alignment during
transition from motion to force. In gray we emphasize 3 specific times (A, B,
reference). B. The coordination pattern vectors (m(t)) for these 3 specific times
(A, B, reference). Measuring the alignment between vectors (θ(t)) allows us to
make quantitative comparisons, the coordination pattern at time A is further
away from the reference than the coordination pattern is at time B. The 3D
space is defined by each of the muscles where the EMG signal was acquired. . 82
6.3 Coordination pattern alignment and magnitude of a representative subject. A.
Coordination pattern alignment and their sigmoidal fits during transition from
motion to force where the surface of contact was either smooth-small (dashed-
blue) or rough-large (in red). B. Coordination pattern magnitude during tran-
sition from motion to force where the surface of contact was smooth-small
(dashed, blue) or rough-large (in red). C. Same as in A after the coordination
pattern alignment was normalized and smoothed by a moving average of 50
ms. D. Same as in B after the coordination pattern alignment was normalized
and smoothed by a moving average of 50 ms. . . . . . . . . . . . . . . . . 85
xiv
6.4 Empirical averaged coordination pattern alignment and magnitude. A. Nor-
malized, smoothed coordination pattern alignment after been averaged across
all trials separated by task difficulty i.e. smooth-small (dashed, blue) and
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CHAPTER 1
INTRODUCTION AND ORGANIZATION
In recent years, there has been increased recognition of the heavy toll of strokes
on humans. While the consequences from large strokes are well defined, in part
because they have high mortality and morbidity rates, less studies exist about
strokes of smaller size. This type does not present obvious symptomatology and
their impact on human health remains controversial. Strokes can be caused by
the rupture of (hemorrhagic stroke) or by an occlusion of (ischemic stroke) a brain
vessel.
In this dissertation I studied hemorrhagic strokes, with emphasis on microhe-
morrhages. I put together current knowledge on brain microhemorrhages, adding
findings from my experimental work and interpretations. The main objective of
this work is to understand damage caused to human health by these lesions with
the end goal of improving treatments. Using an animal model to create hemor-
rhages, I discerned two main questions. First, whether or not most common used
thrombolytic drugs and anticoagulants induce larger brain hemorrhages. Second,
whether small hemorrhages damage neural function, and to what extent.
Chapter 2 begins with an explanation of the techniques I used to study microhe-
morrhages. Using calcium imaging together with two-photon excited fluorescence
microscopy (2PEF) I was able to look at neuronal function in live animals. To
induce hemorrhages on the brain of rodents, I used femtosecond laser pulses on
the vessel wall.
Chapter 3 is a compilation of literature reviews on intracerebral hemorrhage
with an emphasis on microhemorrhage. Topics include the definition of micro-
hemorrhages and how they are detected clinically, current models used to study
microhemorrhages, activated molecular pathways after hemorrhages, summary of
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results from experiments finding cellular damage by hemorrhages and finally asso-
ciation of microhemorrhages in patients with neurological deficits.
Chapter 4 describes experimental work done to characterize the size of hemor-
rhages induced on mice when they were treated with the following drugs: tissue
plasminogen activator, dabigatran etixilate, heparin and warfarin. This chapter
contains my work from a collaboration resulting in two manuscripts submitted to
peer-reviewed journals.
Chapter 5 contains the results of experiments using live rodents, fluorescent
dyes and multiphoton microscopy to characterizes neuronal damage after laser-
induced microhemorrhages. I quantifed the response of neurons to a peripheral
stimulus and compared the neural responses before and after a microhemorrhage
was induced. Acute and chronic experiments were performed to assess where and
when neurons recover their ability to respond properly to stimulation.
Chapter 6 describes work done during my first two years in the Ph.D program
characterizing electromiographical signals from the index finger muscles during
force and movement production in humans. The nervous system uses different
strategies to control force and movement. A model is presented to describe the
transition between these two strategies. This research was originally published in
the Journal of Neurophisiology.
The last chapter is a brief summary of the results presented throughout the
dissertation, pointing out future areas of research.
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CHAPTER 2
TECHNIQUES
3
2.1 Calcium Imaging
Examining changes of free calcium ions (Ca2+) in the intracellular concentration
of neurons is an alternative to the conventional method which records action po-
tentials with electrodes to study neural activity. When calcium changes expressed
as changes in fluorescence and electric activity are monitored simultaneously on
neurons, it has been demonstrated that calcium spikes follow very closely to each
of the action potentials (figure 2.1) [25, 51, 181, 182]. This section reviews the
calcium imaging technique using fluorescent calcium indicators [144].
Figure 2.1: Calcium changes correlate with action potentials, adapted from [51].
2.1.1 Advantages and Applications
The main advantage of calcium imaging is that it allows for monitoring of neural
activity from multiple cells at the same time with minimal or no disruption of
the cell membrane. However, the challenge in calcium imaging is to achieve a
reasonable signal to noise ratio and temporal resolution, which mainly depend on
the hardware used to excite and record fluorescence. The use of calcium imaging
on biological experiments has become widely adopted and it is a valuable tool to
study topics such as neuronal networks [30, 42, 43, 78, 113, 140], learning and
memory [31, 35, 45, 143], development and death of neurons [93, 106, 128], cells
under pathological conditions [28, 32, 164], etc. In this work we used calcium
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imaging to study neural response before and after cortical micro-hemorrhages.
2.1.2 Calcium Dynamics in Neurons
When neurons are at rest they have a membrane potential of -60 mV and a low
intracellular Ca2+ concentration of ∼0.1 µM. There is a high Ca2+ concetration
gradient across neuron cell membranes because the extracellular Ca2+ concentra-
tion is 1-2 mM [3].
During an action potential, the electrical depolarization of the cell membrane
causes voltage-dependent calcium-selective ion channels to open [142], and the cy-
tosolic Ca2+ concentration increases to levels of 1 µM or more. Calcium is either
sequestered (by the reticulum endoplasmatic, mitochondria, nucleous) or interacts
with binding proteins (calmodulin, phospolipades, krumaffin, K+ channels, and
others) inside the cell [4]. Upon binding to proteins that function as receptors on
vesicles filled with neurotransmiters, Ca2+ signals for protein conformations that
will enable the fusing of the vesicles to the presynaptic membrane to deliver their
content (neurotransmitters) into the synaptic cleft [61]. The amount of neuro-
transmitter released is proportional to the number of open calcium channels that
occurs within 200 µs of the action potential arriving at the synaptic terminal [135].
Voltage calcium channels are closed at the end of the action potential, and calcium
ions left inside the cell return to the extracellular space through the Ca2+-ATPase
pump of the cell membrane or by the sodium-calcium exchanger [29, 75]. Fig-
ure 2.2 illustrates the simplified steps that occur during the synapses between two
neurons.
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Figure 2.2: Neuronal synapses. 1) Action potential leads to the opening of the calcium channels.
2) Calcium ions rush into the cell. 3) Proteins that enable docking of vesicle get activated
with Calcium. 4) Vesicles open, and neurotransmitter is released into the synaptic cleft. 5)
Neurotransmitter binds to receptors in postsynaptic neuron or is reabsorbed by presynaptic
neuron. 6) Receptors open ion channels resulting in an excitatory or inhibitory postsynaptic
potential (EPSP or IPSP).
2.1.3 Types of Dyes
Fluorescent calcium dyes, act as calcium buffers and their emission spectrum are
dependent on the calcium concentration of the media (i.e., their fluorescence prop-
erties will change when bound to Ca2+). Calcium dyes are able to detect intracel-
lular free calcium ion concentration between the range of <50 nM to >50 µM [114].
They have an EGTA (ethylene glycol tetraacetic acid) or BAPTA (1,2-bis(o-
aminophenoxy)ethane-N,N,N’,N’-tetraacetic acid) structure (figure 2.3), which
will give the high affinity to Ca2+ [118].
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Fluorescent Ca2+ Indicators 131 
EGTA 
Bapta 
Fig. 1. The structure of EGTA (top) is compared to that of bapta (bottom). 
Both compounds exhibit a single octa-coordinate binding site for Ca2’. One 
oxygen from each of the four carboxyl groups, the two tertiary amino groups, 
and the two ether-linked oxygens all contribute to Ca2’ binding. Bapta dif- 
fers from EGTA in that the amino groups of bapta are aromatic and are not 
significantly protonated at pH 7.0. 
2. Properties of Fluorescent Ca*+ Indicators 
2.1. Chelation Properties 
The fluorescent Ca% indicators including fura-2, indo-I, and 
fluo-3, derive their Ca%-binding properties and ion selectivity 
from bapta (Tsien, 1980; Grynkiewicz et al., 1985; Tsien and 
Minta, 1989). Bapta is a tetracarboxylate analog of EGTA (see 
Fig. l), cleverly designed by Roger Tsien to be pH-insensitive in 
the physiological pH range while retaining high affinity and se- 
lectivity for Ca2+ over Me. Bapta contains a single high-affinity 
binding site for Ca%, w hich involves coordination of one Ca% 
Figure 2.3: The structure of EGTA and BAPTA, taken from [118].
Fluorescent Ca2+ dyes are commonly prepared in the form of salts, dextran
conjugates or acetoxymethyl (AM) esters [114]. When in the form of salts or
dextran conjugates, they need to be deposited directly into the cell membrane by
loading methods such as electroporation or intracelullar injections. In contrast,
calcium dyes in AM ester form can cross the cell membrane, therefore they need
to be loaded in the extracellular space (bulk-loading labeling). This is achieved by
injections into the brain of an animal when in-vivo labeling of neurons is desired.
Bulk-loading in the extracellular space results in the labeling of multiple cells (∼500
µm2 area). In this work, a calcium dye in AM ester form, Oregon Green Bapta
(OGB), is used. In general, AM ester calcium dyes need to be mixed in a 20%
solution of Pluronic F-127 with anhydrous dimethylsulfoxide (DMSO) and further
diluted in physiological media to enable permeability into the cell membrane (see
details about OGB preparation in the appendix). DMSO prevents the AM ester
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from being hydrolyzed until it is in the cytoplasm. Pluronic F-127, a dispersing
agent, increases OGB solubility in the physiological media [114, 144].
Calcium dyes in AM ester form are permeable to cell membrane and once inside
the cell, the AM groups from the dye bind to intracellular enzymes (esterases)
resulting in free dye which is impermeable to membrane and is able to bind to free
Ca2+ from the cytoplasm. Other products such as formaldehyde and acetate may
also be formed in this process (figure 2.4) [52, 147, 118].
Fluorescent Caz+ lndica tors 143 
Cells differ in their ability to accumulate and fully hydro- 
lyze the AM ester derivatives. Most plants, fungi, and many 
marine invertebrates metabolize the AM esters too slowly to be 
loaded by this approach. In the worst cases, the AM ester is the 
major fluorescent component in the cell after loading. Unhydro- 
lyzed dye in the cell is especially serious when using ratiometric 
indicators, the results being underestimation of [Ca”+] and small 
changes in ratio during [Caztll transients (se  Almers and Neher, 
1985; chapter by Moreton in this vol.). Where the loading and 
hydrolysis are good, residual AM ester constitutes ~5% of the 
total indicator fluorescence in the cell. Achieving a good degree 
of hydrolysis is therefore a prerequisite to any quantitative use 
of the fluorescent Ca2-’ indicators. Experimentation can some- 
times lead to significant improvements in loading because cells 
with good potential for loading can, under some conditions, load 
p orly. 
0 
b d-O- + i 
P 
H- -H t CH,C-O- t H’ 
Free dye Formaldehyde Acetate 
(2) 
3.2.2. Formaldehyde as a Byproduct 
of Acetoxymethyl Ester Hydrolysis 
As can be seen above, hydrolysis of the AM ester group 
yields a free dye-carboxylate group, acetate, H+, and formalde- 
hyde. Formaldehyde is known to be toxic and is therefore of 
some concern. To date, the most serious examples of formalde- 
hyde toxicity relate to the use of quin2 or fura- in retinal rod 
outer segments, which are especially sensitive. One of the im- 
portant effects of formaldehyde is the inhibition of glycolysis, 
which seems to explain its toxicity to retinal rod outer segments 
(Winkler, 1981). Problems stemming from formaldehyde toxic- 
ity have been avoided, even in rod outer segments, by using 
enriched media and loading cells in a relatively large volume of 
solution so as to dilute out the formaldehyde (Korenbrot et al., 
1984). Pyruvate and ascorbate are two components in enriched 
media that appear to protect cells from formaldehyde (Garcia- 
Figure 2.4: Inside the cell, acetoxymethyl esters are cleaved to cellular esterases, taken
from [118].
Calcium indicators can be classified into either single wavelength or ratiometric
dyes. Ratiometric dyes shift their excitation or emission spectra when bound to cal-
cium (e.g., Fluo3, Calcium Green 1). Single wavelength dyes increase fluorescence
intensity without changing wavelength (e.g., Indo1, Fura2). The type of indicator
may depend on the length of the experimen and whether to al calcium concen-
trations or changes in the concentrations need to be quantified. Photobleaching,
uneven loading and dye hidrolysis are common problems associated with calcium
imaging using fluorescent dyes. These problems need to be considered especially
when looking at total calcium concentrations where the use of ratiometic dyes is
more recommended [114]. Single wavelength dyes allow for a simpler microscope
design and the simultaneous use of more fluorescent dyes.
In this work, we examined calcium transients with changes in fluorescence with
respect to a baseline (dF/Fo) and compared them to the same cell at different
time intervals, thus controlling for uneven dye loading. In addition, photobleaching
is limited since we used two-photon excited microscopy(2PEF). The type of dye
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chosen was Oregon Green Bapta (OGB), a non-ratiometric dye.
2.1.4 Genetically Encoded Calcium Indicators
Recently, calcium indicators were able to be introduced by gene transfer tech-
niques into live organisms resulting in the fluorescent labeling of intracellular cal-
cium. These types of indicators facilitate long term calcium measurements because
they do not metabolize over time and the loading phase is absent. They combine
proteins with high affinity to calcium such as Calmodulin or Troponin C with
fluorescent proteins [41].
Genetically encoded calcium indicators are being successfully used to image
small animals such as worms, fruitflies, zebrafish, and brain sections, however they
are not as efficient as the calcium dyes when imaging neurons inside brains of larger
animals. Hasan et al. [56] achieved steady expression of flash pericam, IP, CaMP,
Cg2, and cameleons indicators in neurons of mice over 12 weeks. Heider et al., [58]
recorded activity from the visual cortex of monkeys over a period of 10 months.
Genetically encoded indicators have some flaws, namely;
1. They are not able to detect action potentials with precision [96, 41].
2. They are not bright enough, providing a low signal to noise ratio.
3. The amplitude of the calcium transients in vivo are smaller (by a half or more)
than the amplitude of calcium transients produced with calcium dyes under the
same conditions or in situ [167].
4. They can be affected by temperature changes [96].
5. Fluorescent proteins may become nonresponsive [63].
Figure 2.5 shows two regions of the visual cortex of mice where cells were labeled
with either OGB-1 (ester dye) or TN-XXL (genetically encoded indicator). Similar
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calcium responses to visual stimuli were obtained but neurons labeled with OGB-1
were brighter and had larger amplitudes in their responses [95].
Bulk loaded calcium dye: OGB-1AM Genetically encoded indicator: TN-XXL
Figure 2.5: Visual cortex of mice where cells were labeled using OGB-1 AM calcium dye or the
calcium indicator (TN-XXL) was genetically encoded into the cells, scale bar=10µm, adapted
from [95].
Given the above limitations of genetically encoded indicators and the impor-
tance to measure the amplitude of calcium transients in the project, we could not
employ this technique. Improvement of genetically encoded indicators will enable
a simplified way of monitoring neuronal activity in a non-invasive way, and it may
be able to replace calcium dyes in the near future.
2.2 Multiphoton Microscopy
Multiphoton microscopy (MPM) is widely used to image deep inside live animals
or tissue with submicrometer and millisecond time resolution, non-invasively [186].
In this dissertation I used MPM, in particular two-photon excited fluorescence
microscopy to image cells and vasculatory in the cortex of rodents reaching a
maximum depth of 300 µm.
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2.2.1 Principles of Nonlinear Microscopy
Molecules and atoms may transition from their ground state to an excited state
when they absorb enough energy in the form of light for one of the electrons to
move to an orbital of higher energy. When the molecule or atom returns to its
ground state, it can lose the acquired energy through internal conversion, heat,
light or a combination. Molecules that emit light when they return to ground
state are known as fluorophores. Emitted photons have less energy than absorbed
photons.
Commonly, fluorophores are introduced inside live animals to label structures
of interest, however they can also be encountered naturally in some cells. With
the use of spectral filters we can use different fluorophores simultaneously to be
able to distinguish the light emitted by each of them.
The minimum energy that enables the transition of an electron to a higher
electronic excited state (to generate fluorescence) depends on the particular fluo-
rophore, this energy can be given by a single or by multiple photons. The energy
of a photon is inversely proportional to its wavelength (E = hc
λ
, where h is Plancks
constant and c and λ are the speed and wavelength of light in vacuum, respec-
tively). Thus, multiple photons of longer wavelengths can provide the same amount
of energy as a single photon of shorter wavelength.
In two-photon microscopy, the energy from two photons must be transferred to
an electron in a single quantized event (within an interval of about 10E−18seconds)
to bring the molecule to an excited state, see figure 2.6B. The probability of two-
photon absorption increases with the square energy of the incident light and only
occurs in a high photon density medium. Therefore, only at the laser focus two or
more photons can be absorbed by the same electron almost instantaneously. This
non linear absorption process makes possible the imaging of single planes (∼1
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µm) with depth [24, 146], in contrast with linear absorption where all fluorophores
along the laser beam path get excited and generate fluorescence at all planes, see
figure 2.6A.
A
linear 
absorption 
Ground
state
Excited
state
two-photon absorption
B
nonlinear
 absorption
Figure 2.6: Non linear microscopy. A. Linear versus non linear absorption of photons, non
linear absorption allows imaging of a single point in a volume. B. Jablonski diagram of two
photon absorption by a fluorophore, adapted from [59].
Short pulsed lasers with pulse durations between 50 and 100 fs and high rep-
etition frequency are generally used as the source light for in vivo imaging using
non-linear microscopy. This procedure reduces thermal damage while providing
high peak power and peak intensity with low average power [24]. In this work,
we use 100 fs and 300 fs laser pulses with frequencies of 87 MHz and 1 MHz,
respectively. The 100 fs pulses are generated by a Ti-sapphire laser which can
be tuned from 800 to 900 nm wavelength and the 350 fs pulses by a YB-fiber
oscillator/amplifier laser with a fixed wavelength of 1045 nm.
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2.2.2 Limitations
The imaging depth into live organisms using two-photon microscopy is limited
by the scattering of the excitation and emission light while propagating through
the medium. Although excitation photons do not get absorbed by molecules out-
side the laser focus and longer wavelengths scatter less, excitation light still can
get deviated and the number of photons reaching the focus decreases exponen-
tially with depth [44, 138]. Thus, the fluorescence at the focal plane reduces
proportionally to the square of the fraction of unscattered excitation photons,
F ∼ [Poexp(− zls)]2 where Po is the power at the imaging surface and z is the
imaging depth [7, 112, 119].
The emitted fluorescence light also scatters, affecting collection efficiency; the
amount of scattering depends on imaging depth and field of view. The laser inten-
sity for excitation needs to be optimized to produce maximum fluorescence without
saturation, photodamage and photobleaching [25, 81, 66, 115]. In two-photon mi-
croscopy, photobleaching and photodamage are limited, permitting longer imaging
times as compared to linear microscopy. With current laser powers in vivo, two-
photon imaging in brain is possible to 1000 µm deep [24, 60, 12].
The use of two-photon imaging can be limited by the existence of fluorophores
that target the structures of interest. In addition, some fluorophores may have
overlapping emission spectra making it difficult or impossible to distinguish the
fluorescence associated with each fluorophore individually.
2.2.3 Two-photon Microscope Design
In a two-photon microscope, the image is formed by detecting the emitted fluo-
rescence when the laser focus is scanned at very fast rates through the sample.
Scanning of the laser through the sample is achieved with two mirrors that semiro-
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tate. The field of view and image acquisition rate depends, in part, on the degree
of rotation of the mirrors and their speeds, respectively. In a conventional two-
photon scanning microscope, a trade-off between spatial and temporal resolution
exists. Mirrors and lenses are used to resize and guide the laser beam from the
laser source to the scanning mirrors and to the back of the objective [146]. A
prism compensator may be used to avoid lengthening of the laser pulse, resulting
in loss of pulse intensity. Fluorescence from the sample is emitted at all angles
and only part of it will be collected by the objective. A high numerical aperture
(NA) of the objective improves transmission and collection of light and resolvable
distance (R). NA is equal to the refractive index times the sine of half the objective
angular aperture (NA=n*sinθ). R depends on NA as R=0.61 λ
NA
where λ is the
illumination wavelength. Fluorescence collected by the objective passes through
a dicrohic beam/splitting mirror which blocks the reflected excitation light and
separates the fluorescence light. More filters are generally used to further obtain
the desired wavelength range. Finally, light from each of the channels pass trough
a photomultiplier tube which converts it into voltages. The measured voltages are
amplified and digitized. A computer program is used to control the scanning mir-
rors and to display an image based on the voltages from the photodetector and the
position of the mirrors. A schematic of the basic parts of a non-linear microscope
is shown in figure 2.7
2.3 Laser Ablation
Non-linear interactions can lead to breakdown of the material that is being ir-
radiated when the energy levels are high enough to cause ionization rather than
excitation. Similar to two-photon microscopy, this high energy is achieved only
at the focus of an objective, limiting the damage to a single spot of ∼femtoliter
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Photomultiplier
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Figure 2.7: Schematic of a multiphoton microscope, adapted from [59].
sized volume (Fig. 2.8). To ionize a molecule, the electrons of the molecule need
Only peak laser intensity at focus drives optical damage
Intensity is not enough to produce damage.
Intensity is not enough to produce damage.
Figure 2.8: Ablation with fs-laser pulses is limited to the laser focus. Outside the focus the
energy is below the tissue damage threshold restricting breakout to focus where molecules are
ionized.
to be freed from their molecular orbitals, thus the electrons need to receive enough
energy to overcome their electron binding energies (mainly bandgap energy) [159].
Photons that have energies less than the band-gap energy may be absorbed or scat-
tered but will not achieve photoionization. In the initial steps of plasma ablation,
photoionization occurs via multiphoton absorption or tunnel ionization (interaction
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with the electric field of the laser). The electrons that are freed keep increasing
their energy by a process known as inverse Bremsstrahlung, in which the elec-
trons absorb photons while colliding with molecules. After several Bremsstrahlung
events, the energy of the electrons is high enough to ionize other molecules in
ground state by a subsequent collision (impact ionization), resulting in generation
of another free electron (the first electron looses some energy but remains free).
The electrons undergo the same process repeatedly (Bremsstrahlung and impact
ionization) creating an avalanche ionization until all the molecules in the focus are
fully ionized (plasma). At the end of the pulse, plasma, free electrons and ionized
molecules at the focus recombine and energy from the electrons is transfered to
the material resulting in the formation of a cavitation bubble and transformation
of the material, see figure 2.9. Sometimes if the cavitation bubble is large, it may
extend the damage to the material outside the volume ionized [14, 13, 129, 159].
Figure 2.9: Ablation process using high energy femtosecond laser (figure provided by Chris
Schaffer)
In the experiments described in this work, similar to [109, 127], we induced
laser ablation on brain vessels using 50 fs duration laser pulses at 1 kHz repetition
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rate produced by a Ti:Sapphire regenerative amplifier (Legend 1k USP; Coher-
ent), pumped by a Q- switched laser (Evolution 15; Coherent) and seeded by a
Ti:Sapphire oscillator (Chinhook; Kapteyn-Murnane Laboratories Inc.) The ab-
lation laser was set up collinearly with the two-photon excitation laser, entering
the two-photon microscope after the scan mirrors. This permitted visualization of
tissue at the same time that photo disruption is induced.
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CHAPTER 3
HEMORRHAGIC STROKE
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3.1 Types of Stroke
Strokes can be classified by their cause as either hemorrhagic or ischemic, see
figure 3.1, or by their size and symptomatology as either symptomatic (large) or
silent (small, <5 mm), see figure 3.2. In the clinical setting, strokes that are small
and ischemic are usually referred to as infarcts, while strokes that are small and
hemorrhagic are known as microbleeds.
Ischemic Hemorrhagic
Types of Stroke
Figure 3.1: Strokes can be either ischemic or hemorrhagic. Ischemic strokes are characterized
by a blockage in the blood supply while in hemorrhagic strokes the vessel ruptures and blood
spills into the brain.
Hemorrhage location may vary a lot across patients but occurs most commonly
in the cortex, subcortex , basal ganglia, thalamus, brain stem, and cerebellum [122].
Some factors have been identified to increase the risk of developing hemorrhages,
for example, impaired coagulation, arteriovenous malformation, metatastic tumors,
trauma, hypertension, advanced age, cerebral amyloid angiopathy and leukoaraio-
sis [122]. It has been difficult to distinguish whether some of these factors or
hemorrhage locations are associated exclusively to a type of hemorrhage since
many clinical studies have found that large hemorrhages sometimes developed in
the same location as previous microbleeds [80, 148]. However, repercussions in
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human health and mechanisms of injury depend on hemorrhage size.
Large Hemorrhagic Stroke Small Hemorrhagic Strokes
 or Microbleeds
A. B.
Figure 3.2: MRI of large and small hemorrhages in a 77 year old woman. A.Right putaminal
intracerebral hemorrhage. B. Multiple microbleeds in the cortex and subcortex. Figure adapted
from [80].
3.2 Symptomatic Hemorrhages (Large)
Symptomatic intracerebral hemorrhages account for 15% of all stroke cases and
patients develop symptoms such as confusion, distortion of the speech, paralysis,
etc. MRI or CT are usually necessary to differentiate them from ischemic strokes.
They have a high index of disability and mortality rate. It is estimated that only
40% of patients survived more than a year after hemorrhage onset [121, 37] and
many of the patients remain with motor and behavioral deficits. Figure 3.3 enlists
the clinical impact of large hemorrhages on human health.
During a large brain hemorrhage, the intracranial pressure increases, resulting
in tissue displacement, compression of the thalamus and brain stem, edema forma-
tion, brain herniation and death of the patient [175, 2]. Besides mass effects, other
mechanisms of injury are associated with the disruption of the blood brain barrier.
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Blood is highly toxic to brain cells; for example, high levels of glutamate from
blood in the extracellular medium results in excitotoxicity, lactic acidosis and cell
death. Blood components alone have been proven to cause apoptosis and necrosis
in neurons (figure 3.6).
Pathology reported in literature from 
animal models and human postmortem 
tissue  
Type of Hemorrhage (by size) 
intracranial pressure  L 
accompanied by ischemia  L 
microglia  L, MB, MH 
macrophages  L, MB, MH 
limphocites  L, MB, MH 
hemo‐oxigenase  L, MB, MH 
metalloproteases  L, MB, MH 
oxidative stress  L, MB, MH 
neutrophils  L, MB, MH 
iron  L, MB 
glutamate  L 
lactate  L 
apoptosis  MB 
necrosis  L, MB 
caspases  L 
cathepsin  L 
autophagic vacuoles  L 
citocrome C  L 
L=Large (>5 mm), MB=Microbleed (<5 mm and >1 mm), MH=Microhemorrhage(<1 mm) 
 
Consequence on human health  Type of Hemorrhage (by size) 
brain herniation L 
death L 
motor deficits L 
behavioral deficits L 
Alzheimer disease MB, MH 
microangiopathy MB, MH 
vascular dementia MB, MH 
cognitive dysfunction L, MB, MH 
processing speed L, MB 
executive function L,MB 
memory L,MB 
attention L,MB 
L=Large (>5 mm), MB=Microbleed (<5 mm and >1 mm), MH=Microhemorrhage(<1 mm) 
Hemorrhagic Stroke 
Classification by size: 
Hemorrhage size correlates with outcome 
Large, 
Figure 3.3: Impact of brain hemorrhages on human health.
When the int acranial pressure is controlled, the amount of bleeding into the
br in determines the amount of brain damage and outcome of the patients [8, 122,
99], however hemorrhages may expand within one day of onset [2, 76, 178, 9].
3.3 Silent Hemorrhages (Small)
Recently, with advancements in imaging technology, small hemorrhages have been
discovered in the brain of humans. These types of hemorrhages result from the
rupture of small vessels, they do not present obvious symptoms (silent) and are
not life threatening. To be classified as small hemorrhages or microbleedings, their
size has to be less than 5 mm [111].
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3.3.1 Detection of Silent Hemorrhages
For clinical use, gradient-echo T2∗-weighted MRI is the most sensitive current
method to detect microbleeds [131]. Blood causes focal dephasing of the MRI signal
and hemorrhages appear as dark spots on brain T2∗-weighted MRI [111]. White
matter changes and clots have different appearance (brighter) on T2∗-weighted
scans [125].
The appearance of microbleeds on the MRI range from 2 to 5 mm, however in
post-mortem tissue of humans it is also common to find hemorrhages of smaller
size. In this dissertation, the term microhemorrhage is used to refer to microbleeds
with a diameter of several micrometers (<1 mm). MRI images do not represent the
true size of microbleeds, usually they appear larger (∼1.5 times) due to a blooming
effect from the MRI [132]. Detection using MRI is not always reliable, furthermore
detection of microhemorrhages using T2∗-weighted MRI has not been assessed. In
studies that correlate MRI with histology examinations, additional bleedings have
been found in the histological sections that were not previously detected by MRI,
sometimes contrarily, microbleeds detected with MRI could not be confirmed by
histology [38]. Figure 3.4 shows a hemorrhage of ∼150µm diameter found in a
post-mortem human brain.
3.3.2 Effects of small hemorrhages on Human Health
Microbleedings have been detected in healthy people with no evidence of symp-
toms, Roob et al. found that in a sample of healthy individuals between 44 and
79 years old, 6.4% of them had microbleeds. Since MRI does not reliably detect
microbleeds that are smaller than 1 mm, a much greater incidence is expected.
When reviewing the incidence of microbleeds in people that suffer from dif-
ferent disease conditions, microhemorrhages were mostly found in patients that
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50 µm
Figure 3.4: Presence of microhemorrhage on postmortem human brain. Figure adapted
from [21]
had a previous symptomatic hemorrhage (68%) or people with cerebral microan-
giopathy (57%). Microbleeds were also found in people with vascular dementia
and Alzheimer disease, but 70% of these patients also displayed cerebral microan-
giopathy [160]. A general agreement exists on the prevalence of microbleeds among
patients with Alzheimer disease, in these cases, microbleeds appear to occur more
often in the brain cortex and subcortex [55, 103].
In addition to being warnings signs for a major stroke, Alzheimer disease and
microangiopathy, microbleeds appear to have repercussions in cognitive function.
Several studies have found strong correlation between them and cognitive impair-
ment. It has been shown that processing speed, executive function, memory and
attention is worse among patients with microbleeds when they are compared with
controls [171, 120, 80]. Location and number of microbleeds are also relevant to
the degree of cognitive impairment.
Fewer studies have looked at the incidence of microhemorrhages (microbleeds
smaller than 1 mm) in human brains. This is because the only accurate way to
localize them is through meticulous examination of finely sliced post-mortem brain
23
tissue. Similar to larger microbleeds, microhemorrhages have been found in healthy
individuals as well as in patients with Alzheimer disease, however they are more
abundant on Alzheimer cases [21].
Studying damage caused by microbleeds has many challenges, one of them is
that they are frequently accompanied by other types of vascular lesions such as
infarcts, that occur with Cerebral Autosomal Dominant Arteriopathy with Subcor-
tical Infarcts and Leukoencephalopathy (CADASIL) patients, or amyloid plaques
present in Alzheimer patients. Distinguishing the different pathologies associated
with each type of lesion is key to understanding what causes cognitive decline.
Figure 3.3 summarizes the clinical impact of small hemorrhages on human health.
3.4 Models to Study Hemorrhages
The four common animal models used to study brain hemorrhage are: injection
of blood or its constituents, injection of bacterial collagenase, transgenic animals,
and laser ablation of vessel wall.
Different volumes of blood or blood constituents can be injected into the brain
of animals in an effort to replicate the effects caused by a hemorrhage. In this
type of model the needle will cause damage to the tissue and blood may come
back through the needle injection path. Another disadvantage is that the blood
vessel is not disrupted; and this may not reproduce some of the molecular pathways
involved in hemorrhages. The smallest hemorrhage volume achieved with this type
of model is around ∼5 µl [10, 104].
Bacterial collagenase, an enzyme that disrupts the basal lamina of blood ves-
sels, can also be injected into the parenchyma of animals to study intracerebral
hemorrhage. Injection of collagenase causes bleeding over an extended period of
time and deteriorates neighboring tissue usually affecting more than a single vessel.
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Another main disadvantage of using collagenase is its neurotoxicity [126, 145, 169].
These types of hemorrhages are very diffuse and the smallest achieved size reported
in literature using this model is 1 to 2 mm diameter in transversal area [101]. Hem-
orrhages created injecting collagenase cause more damage compared to those made
by the blood injection intracerebral hemorrhage model (figure 3.5) [94].
Figure 3.5: Blood and collagenase models. Schematics of hemorrhages induced by either col-
lagenase or blood injection. Hemorrhages had initial similar amount of bleeding, but collagenase
injection hemorrhages had greater hematoma size and damage 6 weeks after, taken from [94].
Syndromes characterized by the presence of microbleeds such as hypertension
and Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and
Leukoencephalopathy (CADASIL) can be induced in mice to produce naturally
occurring small hemorrhages including microhemorrhages. Hypertension is caused
by disruption of the angiotensin system either by overexpression of angiotensin
genes in engineered mice [68, 166] or by administration of Angiotensin in wild type
mice [165]. CADASIL mice may also be engineered by mutation of the NOTCH3
gene [73]. The main disadvantages of these genetically created models are that the
number and location of microhemorrhages cannot be controlled and other symp-
toms associated with the syndromes are hard to differentiate from the hemorrhage
pathology.
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A recent model is the use of two photon microscopy and tightly focused, high
energy laser pulses to select and irradiate a specific vessel until it bursts [110].
This model has the advantages of being able to control for the location, quantity
and size of hemorrhage. A range in size from very small (no leakage of red blood
cells, only plasma) to moderate (a red blood cell area with 500 µm diameter) can
be generated by varying the intensity and duration of laser pulses.
3.5 Pathology After a Hemorrhage
Inflammation in the brain tissue has been proven to occur after a hemorrhage, even
in those of small size (microhemorrhages). In larger hemorrhages, inflammation
occurs in addition to the damage caused by the hematoma mass effects.
When blood extravasates from blood vessels, blood components such as ery-
throcytes, leukocytes (granulocytes, monocytes, limphocyte), and plasma proteins
(thrombin, plasmin, fibrin, etc.), make contact with neurons disrupting the extra-
cellular environment. Thrombin is also produced in the brain immediately after
disruption of the vessel wall to initiate coagulation [50].
Thrombin appears to be highly toxic for neurons and astrocytes since in-vitro
experiments have shown cell death after thrombin exposure [11, 77]. However,
literature findings are controversial since Xi et al. [175] have not found negative
effects at low concentrations. Thrombin and extracellular glutamate in the blood
may cause excitotoxic cell damage and lactic acidosis formation [47].
The hemoglobin inside the erythrocytes (oxyhemoglobyn) becomes deoxyhe-
moglobin when erythocytes leave the vessel and one week later change to methe-
moglobyn. In in-vitro experiments hemoglobin causes death of neurons only af-
ter one day of exposure but not before [163]. After a hemorrhage microglia and
monocytes (which will differentiate in macrophages) get recruited from surround-
26
ing areas [137, 23, 100] and participate in degradation and sequestration of blood
products. Literature reports a wide range of times for erythrocytes lysis onset,
varying from 1 to10 days after a hemorrhage [22, 67, 162]. The heme protein in the
hemoglobyn gets degraded into iron, carbon monoxide and biliverdin [163], result-
ing in an increase of the iron concentration. Microglia, macrophages, neutrophils
and iron, all may contribute to cell injury via oxidative stress [54, 141, 67, 163, 184].
Free radical scavengers [174] and iron receptors [163] are also activated to maintain
brain homeostasis, however they may not be enough to restrain oxidative stress,
therefore the amount of bleeding may be an important factor related to degree of
injury.
Pathology reported in literature from 
animal models and human postmortem 
tissue  
Type of Hemorrhage (by size) 
intracranial pressure  L 
accompanied by ischemia  L 
microglia  L, MB, MH 
macrophages  L, MB, MH 
limphocites  L, MB, MH 
hemo‐oxigenase  L, MB, MH 
metalloproteases  L, MB, MH 
oxidative stress  L, MB, MH 
neutrophils  L, MB, MH 
iron  L, MB 
glutamate  L 
lactate  L 
apoptosis  MB 
necrosis  L, MB 
caspases  L 
cathepsin  L 
autophagic vacuoles  L 
citocrome C  L 
L=Large (>5 mm), MB=Microbleed (<5 mm and >1 mm), MH=Microhemorrhage(<1 mm) 
 
Consequence on human health  Type of Hemorrhage (by size) 
brain herniation L 
death L 
motor deficits L 
behavioral deficits L 
alzheimer Disease MB, MH 
microangiopathy MB, MH 
vascular dementia MB, MH 
cognitive dysfunction L, MB, MH 
processing speed L, MB 
executive function L,MB 
memory L,MB 
attention L,MB 
L=Large (>5 mm), MB=Microbleed (<5 mm and >1 mm), MH=Microhemorrhage(<1 mm) 
Hemorrhagic Stroke 
Classification by size: 
Hemorrhage size correlates with outcome 
Large, 
Figure 3.6: Pathology found in brain hemorrhages classified by size.
Over time the hemorrhage is cleared out sometimes leaving hemosiderin de-
posits (iron storage). While in large hemorrhages it is evident that cell death
occu s in neighboring areas via apoptosis and necrosis [176, 49, 37, 98, 97, 122], in
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smaller hemorrhages the presence of cell death remains inconclusive. For example,
Schrag et al. [132] reports 4% of apoptotic cells in neighboring areas after exam-
ining four brain hemorrhages in mice, however the exact size of the hemorrhages
examined was not specified, only a wide range in the diameter hemorrhage from
0.2 to 3 mm was given. While 0.2 mm hemorrhage diameters are a good model
for mimicking microbleeds, a 3 mm diameter in the brain of a mouse may be
too large. Furthermore, caspases [47], nuclear factor-kB complex [62], cytochrome
c [105] and autophagic vacuoles [57], which are associated with cell death have
been only found in large hemorrhages. Figure 3.6 indicates the pathology found
after a brain hemorrhage from different experiments reported in literature using
animal models and postmortem human brains.
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CHAPTER 4
EFFECTS OF ANTICOAGULANTS ON MICROHEMORRHAGES
This chapter contains my work from a collaboration resulting in two manuscripts:
Arne Lauer, Flor A. Cianchetti, Elizabeth M. Van Cott, Frieder Schlunk, Elena
Schulz, Helmuth Steinmetz, Chris B. Schaffer, Eng H. Lo, Christian Foerch. Anti-
coagulation with the Oral Direct Thrombin Inhibitor Dabigatran Does
Not Enlarge Hematoma Volume in Experimental Intracerebral Hemor-
rhage, Circulation, in-press.
Christian Foerch, Nathanael L. Rosidi, Frieder Schlunk, Arne Lauer, Flor A.
Cianchetti, Emiri Mandeville, Ken Arai, Kazim Yigitkanli, Klaus van Leyen, Hel-
muth Steinmetz, Chris B. Schaffer, Eng H. Lo. Intravenous tPA therapy does
not worsen acute intracerebral hemorrhage in mice, PLoS ONE, in-press.
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4.1 Abstract
The early use of anticoagulants as a therapy for ischemic strokes has been lim-
ited when there is uncertainty as to the type of stroke that the patient suffers.
In addition most anticoagulants may exacerbate the bleeding caused by a brain
hemorrhage. However, not all anticoagulants share a similar mechanism and some
of them may not further increase bleeding from a brain hemorrhage, but would
be beneficial in instances where immediate reperfusion is needed or when blood
clotting needs to be continuously inhibited. In particular, this study examine the
effects of Tissue plasminogen activator (tPA), direct thrombin inhibitor dabigatran
etexilate (DE), warfarin and heparin therapy on microhemorrhage size. Using a
laser-induced microhemorrhage model hematoma sizes were compared between the
different therapies administerd to mice with respect to controls. Results demon-
strated that warfarin and heparin treated mice exhibited larger hemorrhages than
controls, however no difference was found between mice treated with DE, tPA and
controls. This suggests that some anticoagulants have greater risks of developing
brain hemorrhages than others, with similar benefits.
4.2 Introduction
Stroke is a major cause of death and long-term disability in the world [180]. Strokes
can be either ischemic or hemorrhagic. Ischemic stroke is nine times more common
than hemorrhagic stroke. Anticoagulation therapies with vitamin K antagonists
are mainly used for treatment of thrombotic and thrombembolic disorders, and
have been highly effective in, for example, reducing the risk of cardioembolic brain
infarction in patients with atrial fibrillation. When ischemic strokes can not be
prevented, recombinant tissue plasminogen activator [187] is commonly use for
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dissolving ischemic clots in the brain.
Some limitations of vitamin k antagonists (warfarin, heparin, etc) are: a narrow
therapeutic window, the need for regular coagulation monitoring and critical food
and drug interactions [6, 133]. In addition, the risk of developing intracerebral
hemorrhage is the most feared complication. Both clinical and experimental studies
revealed that anticoagulation associated with intracerebral hemorrhage (ICH) is a
devastating type of stroke with short-term mortality rates exceeding 50%, due to
increased hematoma volumes and prolonged bleeding [2, 39, 69, 139].
Recently, the search for alternative strategies for long-term anticoagulation has
intensified, to overcome the problems associated with vitamin K antagonists [26,
154]. One possibility, is the use of oral direct thrombin inhibitor Dabigatran etex-
ilate (DE) which binds reversibly only to the active site of the thrombin molecule.
In a clinical trial (RE-LY trial), DE showed significantly reduced rates of stroke
along with a favorable risk-benefit-profile as compared to warfarin in patients with
non-valvular atrial fibrillation [18]. In addition, DE has also been evaluated for
the prophylaxis of thrombotic complications in patients undergoing total hip re-
placement [34]. Furthermore, DE is under investigation for the treatment of acute
symptomatic venous thromboembolism [133] and long-term secondary prevention
of venous thromboembolism [88]. Very limited information is available on the char-
acteristics of ICH occurring during treatment with direct thrombin inhibitors [20].
For both doses of DE used in the RE-LY trial, the incidence of intracranial bleeding
was significantly lower than in the warfarin group [18] Still, bleeding risk increased
dose-dependently. The influence of DE pretreatment on hematoma expansion and
prognosis of ICH in comparison to warfarin remains undetermined.
A diagram of the simplified coagulation cascade and the coagulation factors
that are inhibited by different anticoagulants such as heparin, warfarin and DE
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are shown in figure 4.1.
factor XII factor XIIa
factor XI factor XIa
factor IX factor IXa
factor X factor Xa
Tissue factor
+ factor VIIa 
prothrombin
(factor II)
thrombin
(factor IIa)
fibrinogen fibrin
factor VII
factors inhibited by heparin
factors inhibited by warfarin
free and clot bound thrombin 
are inhibited by DE
Negatively charged
 surface activates XII
Blood vessel damage 
exposures tissue factor
Figure 4.1: Mechanism of anticoagulants on the coagulation cascade. Heparin when bound to
antithrombin inhibits free thrombin and activated factors XIIa, XIa, IXa, Xa. Warfarin, inhibits
the production of prothrombin and factors IX, X and VII by the liver. DE inhibits free thrombin
and clot bounded thrombin.
The main limitation of Tissue plasminogen activator (tPA) application is the
need for its rapid use after a clot occurs and the existence of hemorrhagic strokes
has to be ruled out. The sooner patients receive tPA and reperfuse, the better
the odds ratio for improved outcomes. In current clinical practice, performing a
brain scan is considered indispensable prior to tPA therapy, to avoid inadvertent
administration of tPA to patients with hemorrhagic instead of ischemic stroke [1].
This induces a substantial time-to-treatment delay, as tPA cannot be administered
directly at the patient home or in an ambulance.
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Despite obvious advantages of tPA and that it has been approved by the FDA
for more than 10 years, its use is still limited to less than 5% of all ischemic strokes
due to it being restricted uniquely to cases when ICH has been ruled out. The
widespread assumption that tPA therapy would worsen ICH seems intuitive, but
lacks scientific validation.
In this chapter, using similar methods, we separately tested the effects of the
direct thrombin inhibitor DE and intravenous administration of tPA on hematoma
volume after a microhemorrhage was induced in a mouse.
4.3 Methods
4.3.1 Animals
All experiments were conducted in accordance with the National Institute of Healths
Guide for the Care and Use of Laboratory Animals and procedures were approved
by Cornell University Institutional Animal Care and Use Committee. For the DE
study 9 male CD-1 mice aged 12 to 16 weeks (mean body weight 39.6g) were used.
For the tPA study 11 male and female C57BL/6J mice aged 10-12 weeks (mean
body weight 30 g) were used. Bilateral chronic cranial windows (∼3 mm radius
with center at stereotactic coordinates in relation to bregma: 3 mm posterior, 0 mm
lateral) were implanted in all mice using previously reported methods [110, 130].
4.3.2 Drug Administration
DE Study
Ten days after surgery, animals were blindly and randomly assigned to receive
pretreatment with DE (dosage 75mg/kg, n=3), warfarin(n=3) or PBS (control,
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n=3).
A DE tablet (110mg, Pradaxa, Boehringer Ingelheim, Ingelheim, Germany)
was dissolved with 1% dimethylsulfoxide (DMSO) in saline solution. A solution
with a DE concentration of 20mg/ml was prepared. DE mice were fed three times
orally using a gastric tube with intervals of eight hours. Each feeding consisted
of 0.15 mL of the respective solution resulting in a dose of 75mg/kg body weight
per feeding for a 40g mouse. Control mice were fed three times with 0.15 mL PBS
following the same modus of application. Warfarin was administered via drinking
water following a previously established protocol. For mice with a body weight of
40g, a daily water consumption of 15 mL / 100g provided an estimated warfarin
intake of 0.1 mg (2.5 mg/kg) within a 30 hour feeding period.
ICH induction of laser-induced vessel rupture, respectively, was performed 0.5
hours after the last oral gavage of either DE or PBS and at the end of the warfarin
feeding period.
tPA Study
Five days after surgery and immediately before the imaging session mice were
anesthetized with isofluorane and the right jugular vein was cannulated. After
ligating the distal part of the vessel, a PE-10 tube was inserted into the jugular
vein and moved forward in the proximal direction, then the tube was fixed and
the suture was closed. The animals were placed in a stereotactic frame under the
two-photon microscope.
Animals were assigned to receive intravenous saline (500 µl), recombinant hu-
man tPA (10 mg/kg, diluted in 500 µl saline) or heparin (100 U/kg, diluted in
500 µl saline). Immediately before laser induction of hemorrhage, a 50 µL bolus
injection of saline (n=4), tPA (n=11), or heparin (n=10) was infused through the
jugular vein catheter, then after five minutes a constant infusion rate (15 µL/min)
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was set using a syringe pump (PHD2000; Harvard Apparatus), i.e. 30 min of
drug infusion during and after hemorrhage. The correct intravenous position of
the catheter was double-checked by drawing some blood into the tube after the
injection.
4.3.3 In Vivo Imaging and Hemorrhage Induction
In preparation to induce ICH, mice were anesthetized with isofluorane (∼2.0%).
Body temperature was maintained at 37.5◦C with a heat blanket and a thermome-
ter. A retro-orbital i.v. injection of 0.1 mL of 5% (wt/vol) Texas-Red dextran
(70 kDa) fluorescent dye in physiological saline was given to label the vasculature.
We imaged the brain using in vivo two-photon excited fluorescence microscopy
(excitation source: 1045 nm, 1 MHz, 350 fs pulse train from a Yb-fiber oscil-
lator/amplifier system; µJewel FCPA, IMRA America, Inc.; filter: 645/65 nm
Chroma filter). Bleeding was induced in two to five targeted penetrating arteri-
oles per mouse by injuring the endothelium with tightly focused femtosecond laser
pulses as described in [110]. The laser only causes damage at the focus (∼1 µm2)
leaving the surrounding regions intact(figure 2.8).
Microhemorrhage depth varied between 50 and 120 µm beneath the cortical
surface. The bleedings were separated by at least 1mm between each other. Stacks
of images were taken at the hemorrhage site every 2 µm from brain surface to 150
µm depth. For the DE study, image stacks were taken before and immediately after
(∼5 min) ICH induction while for the tPA study, image stacks were taken before
and 30 min after ICH induction. The laser-induced hemorrhages are characterized
by a core region filled with red blood cells (RBC) and a surrounding blood plasma
region. The RBC core appeared black, while blood plasma is bright, labeled by
the Texas Red dye. To determine hemorrhage size, we measured the diameters of
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the RBC-filled microhemorrhage core and of the surrounding blood plasma-filled
region from a 20 µm z-projection of the stack images centered on the hemorrhage.
4.3.4 Statistical Analysis
Matlab (The mathworks Inc.) and JMP version 8.0 (SAS Institute Inc.) were
used for statistical analysis. Lilliefors and Levenes tests were used to analyze data
distribution and equality of variances. Diameters of the microhemorrhage regions
were compared using Welchs ANOVA and Dunnetts method. Mann-Whitney U
tests were used if data was not normally distributed. P-values less than 0.05 were
considered statistically significant.
4.3.5 Post-mortem histology
At the end of each imaging session for the tPA study, animals were transcardially
perfused with 30 ml of phosphate buffered saline (PBS) (Sigma-Aldrich) and 100-
ml of 4% (wt/vol) paraformaldehyde (Fisher Scientific) in PBS. The brain was
extracted from the skull and cryoprotected by immersion in 30% (wt/vol) sucrose
in PBS for 24 hr and then in 60% sucrose in PBS. Fiducial marks were made in the
left corners of the craniotomy window by vertically inserting a 25 gauge needle 2
mm into the brain. The needle was externally tinted with black ink (Parker). The
fiducial marks were placed in known locations relative to the microhemorrhage
sites. The brain was then frozen and cut into 50 µm thick coronal sections on
a cryostat. The sections were mounted onto microscope slides (Superfrost Plus,
Fisher Sci.) and incubated for 12 min with diaminobenzadine (DAB) (Peroxidase
Substrate kit, Vector labs, no. SK-4100) to stain endogenous peroxidase in RBCs
and then rinsed with deionized water. The sections were photographed under
brightfield and fluorescence microscopy. Fiducials were mapped and used to iden-
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tify the slices and location within slices where microhemorrhages were located.
Microhemorrhages were identified on the basis of both DAB stained RBCs and
Texas Red dextran fluorescence in the parenchymal space (figure 4.2).
DAB for RBC fluorescence for blood plasma
saline
tPA
(10 mg/kg)
heparin
(100 mg/kg)
100 µm
a
b
c
d
e
f
Supplemental figure 2
Figure 4.2: Post-mortem histology of laser-induced microhemorrhages. Representative coronal
post-mortem tissue sections of microhemorrhages from animals treated with saline (a,d), tPA (b
,e) or heparin (c,f). Panels (a-c) show white-light transmission images treated sections, which
show the RBCs that have hemorrhaged into the tissue as black. Panels (d-f) show fluorescence
images of extravasated Texas Red-dextran for the same sections as panels (a-c).
4.4 Results
4.4.1 DE Study
A total number of 12 (across 3 control mice), 13 (across 3 DE mice), and 13
(across 3 warfarin mice) microhemorrhages were induced in each group, respec-
tively (figure 4.3). Both the diameter of the RBC core and the diameter of the
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blood plasma filled region were larger for warfarin-pretreated mice than for con-
trols and DE-treated animals (mean ± SD; controls: 116.2 ± 38.0 µm and 327.8 ±
80.4 µm; DE mice: 108.1 ± 35.2 µm and 331.6 ± 51.2 µm; warfarin mice: 192.8 ±
101.4 µm and 467.5 ± 113.6 µm, respectively; Figure 4.4). The Welchs ANOVA
between group differences for RBC- and blood plasma diameters were significant
(p=0.035 and p=0.003, respectively). Post-hoc analysis revealed no differences in
RBC- and blood plasma diameters between DE-treated mice and controls (p=0.935
and p=0.991, respectively), but warfarin animals had significantly larger RBC and
plasma diameters than both DE mice and controls ( warfarin vs. DE: p=0.008 and
p<0.001, respectively; warfarin vs. control: p=0.013 and p<0.001, respectively).
4.4.2 tPA Study
A total number of 9(across 4 control mice), 11 (across 4 tPA mice), and 10 (across
3 heparin mice) microhemorrhages were induced in each group, respectively (fig-
ure 4.5A). The size of the red blood cell (RBC) filled microhemorrhage core and the
surrounding blood plasma filled region were not different between saline and tPA
treated mice. In contrast, hemorrhages produced while infusing heparin were sig-
nificantly larger than saline controls (RBC area, p=0.0025; plasma extravasation
area, p=0.025). Figure 4.6 show the correspondent box-plots.
We identified 18 femtosecond laser-induced intracerebral microhemorrhages in
post-mortem tissue sections. Across all treatments, we found that RBCs spread
vertically along the perivascular space surrounding the targeted penetrating ar-
teriole(figures 4.2A-C). Blood plasma, however, was able to diffuse through the
parenchyma tissue and exhibited a more extended spatial pattern (figures 4.2D-
F). We consistently observed that heparin treatment led to a larger spherical RBC
filled volume compared to saline and tPA treatments(figures 4.2C and 4.2F).
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100 µm 100 µm
100 µm100 µm
before after
Control
DE
75 mg/kg
Warfarin
“Figure 5”
Figure 4.3: In-vivo 2PEF microhemorrhages, DE study. Projections of in-vivo two-photon
excited fluorescence image stacks of fluorescently labelled blood plasma spanning a 20 µm depth
centered at the hemorrhage origin. Image stacks are shown before and after rupturing the wall
of a single penetrating arteriole using tightly focused femtosecond laser pulses. Representative
examples from the three differently treated groups (saline-treated controls, DE 75mg/kg, war-
farin) are shown. Extravasated plasma is visualized by diffuse fluorescence and can be seen in
the post hemorrhage images in a halo surrounding the target vessel. The dark core immediately
adjacent to the target vessel is filled with red blood cells.
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Figure 4.4: Hemorrhage size for DE study. A.Diameter of red blood cell filled core after
laser-induced microhemorrhage in controls (C) and in mice pretreated with DE (75mg/kg) or
warfarin (n=12-13 microhemorrhages per group). B. Diameter of plasma extravasation volume
after laser-induced microhemorrhage for the same lesions shown in A. Data are displayed using
box plots with the box indicating the median and the 25th and 75th percentile, respectively.
Whiskers extend to the maximum and minimum values that are not outliers. Circles in light
grey represent individual data points. Outliers have a cross imbedded in the circle. The dark
grey circle represents mean without outliers. ∗p <0.05 as compared to controls.
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4.5 Discussion
We investigated in two different studies, the effects of pretreatment with the di-
rect thrombin inhibitor DE before ICH induction and treatment with tPA ad-
ministration after ICH induction on hematoma volume. As positive controls, the
vitamin-K antagonists warfarin and heparin were used on the DE and tPA studies,
respectively. Whereas warfarin and heparin anticoagulation led to largely increased
hematoma volumes, hematomas in DE and tPA treated mice did not differ from
control animals.
4.5.1 DE Study
Our study suggests that DE anticoagulation has much less devastating effects
in case of intracerebral bleeding than warfarin anticoagulation. What might be
the reasons why warfarin but not dabigatran anticoagulation leads to enlarged
hematoma volumes in case of ICH? In vitro investigations revealed that deficien-
cies of the coagulation factors II, VII and X cause delayed clot initiation and affect
clot propagation and clot strength. However, the presence of a small amount of
factor II activity already resulted in clot initiation values similar to those in control
plasma, whereas nearly every decrease of the factors VII and X further increased
time to clot [107]. Following the propagation phase of coagulation, the secondary
thrombin burst leads to the activation of thrombin activatable fibrinolysis inhibitor
(TAFI), leading to down-regulation of fibrinolysis. Direct thrombin inhibitors fail
to inhibit TAFI generation, while drugs that target factor Xa (fondaparinux, hep-
arin and warfarin) enhance plasma fibrinolytic potential [90]. This may contribute
to their increased bleeding potential. Factor II activity by DE mediated univa-
lent, reversible thrombin inhibition may still result in sufficient hemostasis in the
scenario of ICH. Our pathophysiological hypothesis is supported by other animal
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studies that observed a bleeding time prolongation after DE therapy only at supra
therapeutic doses [173]. In addition, a dissociation between antithrombotic efficacy
and absence of bleeding time prolongation was reported in studies using different
oral thrombin inhibitors [91, 116, 123].
In the RE-LY trial, incidence rates of ICH in DE treated patients were found
to be reduced as compared to warfarin treated patients, despite a similar rate of
antithrombotic efficiency. This finding might be linked to the decrease of other
vitamin K dependent coagulation factors (other than factor II) in case of warfarin
anticoagulation and their contribution to hemostasis, while DE does not directly
affect parameters other than factor II [18]. Our experimental study investigating
the behavior of laser-induced cerebral microbleeds after DE and warfarin pretreat-
ment provides a more detailed insight: microhemorrhages induced in warfarin-
treated mice more often expand towards having increased RBC and blood plasma
diameters, whereas microbleeds in DE mice do not differ from controls.
The clinical implication of our findings is manifold: Intracerebral bleeding oc-
curring during warfarin treatment is particularly severe, with short-term mortality
rates of 50% [2]. Clinical and experimental data have shown that hematoma ex-
pansion is prolonged in the case of warfarin anticoagulation, thus leading to larger
hematoma volumes and a worse functional outcome [2, 39, 69, 139]. In warfarin
associated ICH, measures to rapidly reverse anticoagulation may prevent such pro-
longed bleeding and may improve functional outcome [2, 139, 40]. Our data sug-
gest that DE anticoagulation does not facilitate ongoing bleeding and extensive
hematoma growth. It is likely that this is mirrored by better prognosis as well.
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Figure 4.5: In-vivo 2PEF microhemorrhages, tPA study. A.2PEF in vivo image projections of
fluorescently-labeled blood plasma spanning a 20µm depth centered at the hemorrhage origin.
Image stacks are shown before and after rupturing the wall of the a single penetrating arteriole
using tightly focused femtosecond laser pulses. Representative examples from the three different
intravenous infusion groups (saline, tPA, heparin) are shown. Extravasated plasma is visualized
by diffuse fluorescence and can be seen in the post hemorrhage images in a halo surrounding the
target vessel. The dark core immediately adjacent to the target vessel is filled with red blood
cells.
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Figure 4.6: Hemorrhage size for tPA study. A.Area of red blood cell filled core after laser-
induced microhemorrhage in mice treated with saline, tPA and heparin. B. Diameter of plasma
extravasation volume after laser-induced microhemorrhage for the same lesions shown in A. Data
are displayed using box plots with the box indicating the median and the 25th and 75th percentile,
respectively. Whiskers extend to the maximum and minimum values that are not outliers. Circles
in light grey represent individual data points. Outliers have a cross imbedded in the circle. The
dark grey circle represents mean without outliers.
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4.5.2 tPA Study
Our results stand in sharp contrast to the widespread but so far unproven assump-
tion that tPA would enlarge hematomas if inadvertently given to patients with
acute ICH. What might be the reasons why heparin but not tPA administration a
leads to enlarged hematoma volumes in case of ICH? From a mechanistic stand-
point, our data suggest that tPA does not amplify matrix metalloproteinases that
exacerbate neurovascular injury during ICH. But there may be other multifacto-
rial reasons as well. Unlike warfarin and heparin, tPA has no effect on primary
hemostasis and does not delay initial coagulation. But as an activator of the fib-
rinolytic cascade, tPA increases the risk of rebleeding from previously hemostatic-
stable areas [102]. So tPA could theoretically worsen intracerebral bleeding. On
the other hand, the fibrinolytic activity of tPA is highly dependent on parameters
such as clot structure. For example, platelet-rich thrombi are much less suscep-
tible to tPA dissolution compared with erythrocyte-rich thrombi, mainly due to
the release of platelet-derived plasminogen activator inhibitor [70]. Intracerebral
hematomas consist of whole blood containing large amounts of platelets so it is
possible that these structures may be more tPA-resistant. Another possible ex-
planation for our finding is that the ICH clots surrounding ruptured brain blood
vessels are heterogeneous and larger than singular intraarterial thrombi in ischemic
stroke [126]. Standard doses of tPA may not be able to dissolve significant parts
of the coagulated hematoma in order to induce rebleeding. Furthermore, ICH
volumes may be stabilized by the counter pressure of surrounding brain tissue,
which limits hematoma expansion. Together with parenchymal tissue destruction,
elevated pressure in the affected brain areas may prevent systemic intravenously
administered tPA from reaching the initial sites of vessel rupture.
The mechanisms involved in primary ICH are different from those that underlie
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hemorrhagic transformation and reperfusion injury after ischemia. Hemorrhagic
transformation during reperfusion injury are now known to be related to excitotoxic
effects of tPA and neurovascular upregulation of MMPs [53, 169, 179], rather than
the rebleeding of a previously terminated hematoma. tPA may not worsen ICH, but
this is different from potential deleterious effects of tPA during cerebral ischemia
and reperfusion. Our present data support this idea. tPA seems to amplify MMPs
during cerebral ischemia-reperfusion but not ICH.
4.5.3 Summary
Our DE experimental study suggested that cerebral hemorrhages occurring during
DE treatment are smaller and less harmful than those under warfarin anticoag-
ulation. In terms of safety, this may represent a crucial advantage of the direct
thrombin inhibitor DE over warfarin. Our tPA study suggested that intravenous
tPA does not enlarge hematomas or worsen outcomes in ICH, therefore tPA could
be administered at much earlier time points. This may vastly increase the effec-
tiveness of this drug in patients with acute ischemic stroke.
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CHAPTER 5
EFFECT OF MICROHEMORRHAGE ON NEURONS
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5.1 Abstract
Although microhemorrhages are common in the brain of the elderly, the direct
impact of these lesions on neural function remains unclear. In this work, we used
femtosecond laser irradiation to rupture the wall of targeted arterioles in the brain
of anesthetized rodents, producing a hematoma of ∼100 µm diameter. We studied
the impact of these microhemorrhages on neural activity using cell-resolved two-
photon imaging of bulk-loaded calcium-sensitive dye. We monitored peripheral
sensory stimulus-induced calcium transients from individual neuronal cell bodies
and regions of neuropil at different distances from the microhemorrhage before and
0.5, 2, and 4 hours after the creation of the lesion. We found that immediately after
the hemorrhage the average amplitude of the stimulus-induced calcium response
was reduced to about half within 150 µm from the hematoma. Beyond 300 µm,
there was little effect on neural response, with a smooth increase in response ampli-
tude from 150 µm to 300 µm from the lesion. Cortical function gradually improved
with time and by four hours after the lesion the neural response had recovered to
baseline everywhere but within 150 µm from the hematoma. To assess whether the
cells closest to the microhemorrhage recovered over a longer timeframe, we devel-
oped a re-openable chronic cranial window preparation that allowed reinjection of
calcium-sensitive fluorescent dye. We found that the response largely recovered by
one day after the microhemorrhage even within 150 µm from the hematoma. This
work suggests that neuronal function is transiently lost near a microhemorrhage,
but recovers within one day after the lesion.
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5.2 Introduction
Small, acutely asymptomatic, strokes are frequently found in the brain of elderly
patients [158]. These lesions range in size from the several millimeter diameter
strokes observable in MRI studies [80] to lesions only a few tens of micrometers in
size revealed by post-mortem histology [21, 46]. The presence of even the smallest
of these lesions has been associated with cognitive decline and dementia [82, 21].
Similar to large strokes, these microstrokes might be caused by occlusion of or
bleeding from a microvessel, with microclots and microhemorrhages likely affecting
the brain in different ways. Despite the importance of small strokes in neurological
health, little is known about the progression of neural dysfunction following these
lesions.
Following microclots, dendrite degeneration was observed near the ischemic
core and although neural structures remained intact further away, there was an
acute loss of neural activity up to 300 µm from the lesion [185]. This suggests that
microclots cause cell death and neural dysfunction near the lesion, likely explaining
their cognitive impact.
In contrast, it has been difficult to study the pathological consequences of a
microhemorrhage due to the lack of good animal models of small vessel bleeds. Cur-
rent hemorrhage models involve injection of either blood directly into the brain
or enzymes that degrade the extracellular matrix, causing bleeding from many
vessels [94]. Neural death and inflammation was found in the vicinity of these
hemorrhages, however the hematomas created are greater than 1 mm in diame-
ter and the mechanisms that cause cell injury after these lesions may not play
the same role in microhemorrhages. Transgenic mice, such as hypertensive or
CADASIL (Notch 3 mutation) animals, develop microhemorrhages with diameters
of several hundred micrometers throughout the brain, which have been shown to
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trigger inflammation [165, 5]. However it is difficult to follow the effects of mi-
crohemorrhages on cells in these animals because of the unpredictable timing and
location of the lesions. Finally, extravasation of blood plasma into the brain due
to a nearby ischemic lesion did not cause dendrite degeneration [185].
Here, we investigated changes in neural function after a single microhemor-
rhage. We used femtosecond laser pulses to rupture targeted arterioles in the
brain of live, anesthetized rodents, creating microhemorrhages of ∼100 µm diam-
eter [110]. We used two-photon excited fluorescence (2PEF) microscopy of bulk-
loaded calcium-sensitive fluorescent dyes [140] to monitor the resulting changes in
neural response to a peripheral stimulus. We found a decrease in neural response
in the vicinity of the hematoma immediately after the bleed that recovered toward
baseline over time, with regions further from the lesion recovering more quickly.
These results show that even the smallest microhemorrhages can lead to transient
loss of neural function, but suggest that any long-term impact is not caused by the
inability of neurons to respond to input.
5.3 Methods
5.3.1 Acute Rat Preparation
All animal procedures were reviewed and approved by the Cornell University In-
stitutional Care and Use Committee. We used 23 adult male Sprague-Dawley
rats (Harlan, Inc.), ranging from 250 to 415 g in weight. Rats were anesthetized
using 5% isoflurane (Vet-one, Inc.) and maintained at 1-2% throughout surgery.
An intramuscular injection of glycopyrrolate (0.5 mg/kg rat) (Baxter, Inc.) was
administered, the head was shaved, and eye ointment applied. The rat was trans-
ferred to a custom stereotaxic frame where bupivacaine (0.1mL, 0.125%) (Hospira,
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Inc.) was administered subcutaneously on top of the head to provide local anes-
thesia. A ∼1.5 mm radius circular craniotomy was performed and the dura was
removed. In order to access the hind paw somatosensory cortex, the center of
the craniotomy was located 2 mm lateral and 1 mm caudal from bregma. After
loading fluorescent dyes into the brain (see below), the craniotomy was filled with
1% agarose (A9793, Sigma) in artificial cerebrospinal fluid (ACSF) [79] and then
sealed with a glass cover slip (50201, World Precision Instruments) that was glued
to the skull using cyanoacrylate and dental cement (Co-Oral-lte Dental Mfg Corp.).
One hour prior to in vivo 2PEF imaging, isoflurane anesthesia was gradually de-
creased to zero, while urethane (U25000, Sigma; diluted in deionized water) was
administered intraperitonealy over three injections (final dose: 1.5 g/kg rat). Ure-
thane was used during our studies of changes in stimulus-induced neural response
after microhemorrhage because it has been reported to both maintain regulation
of cerebral blood flow [149] as well as preserve the neural response to a peripheral
stimulus [124]. Throughout surgery and imaging animals breathed oxygen-enriched
air, body temperature was maintained at 37.5 ◦C by a thermostatically regulated
heating pad (Harvard Apparatus, Inc.), the blood oxygen saturation and heart rate
were monitored using a pulse oximeter (MouseOx, Starr Life Sciences Corp.), and
subcutaneous injections of 5% (w/v) glucose in physiological saline (1 ml/kg rat)
were applied every hour. Animals were sacrificed at the conclusion of the imaging
session.
5.3.2 Chronic Mouse Preparation with Reopenable Cra-
nial Window
We used seven adult C57BL/6 mice (both sexes) ranging from 17 to 32 g in weight.
Animals were anesthetized on isoflurane and eye ointment was applied. Next,
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intramuscular injections of glycopyrrolate (0.5 mg/kg mouse) and subcutaneous
injections of dexamethasone sodium phosphate (0.2 mg/kg mouse) (American Re-
gent, Inc.) and ketoprofen (5 mg/kg mouse) (Fort Dodge) were given. The head
was shaved and cleaned with providone iodine and ethanol. After giving local in-
jections of bupivacaine, a ∼1.5 mm radius circular craniotomy was prepared over
the hind paw somatosensory cortex (center located at 1.5 mm lateral and 0.3 mm
rostral from bregma). The dura was left intact. During all procedures when the
mouse was under anesthesia, body temperature was maintained at 37.5 ◦C by a
thermostatically regulated heating pad and 0.1 mL subcutaneous injections of 5%
(w/v) glucose in physiological saline were applied every hour. After loading flu-
orescent dyes into the brain, a thin ring-shaped wall of silicone (Kwik-sil, World
Precision Instruments, Inc.) was carefully applied around the edge of the cran-
iotomy and then over the exposed mouse skull. The craniotomy was filled with
sterile ACSF and a 5 mm glass cover slip was glued to the silicone using cyanoacry-
late and dental cement. This procedure created a chamber that can be removed
while causing minimal injury to the brain by gently pulling the silicone away from
the skull (figure 5.6A).
After closing the craniotomy, the animal was removed from anesthesia and
allowed to recover for one hour. Animals were then re-anesthetized using isoflurane
for in vivo 2PEF imaging and hemorrhage production. At the end of imaging
session, the mouse was returned to a cage placed on a heating blanket and provided
with wet food. We checked the window clarity and mouse behavior every eight
hours until the next imaging session. Interruption of anesthesia for an hour between
the surgery (2-3 hours) and the initial imaging session (4-6 hours) was found to
improve the survival rate. On the next day, the mouse was re-anesthetized, the
craniotomy was reopened, and fluorescent dyes were reapplied. The craniotomy
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was then filled with sterile ACSF and sealed by gluing a glass coverslip directly to
the skull. After the imaging session the animal was sacrificed.
Fluorescent Labeling of Blood Vessels, Astrocytes, and Neurons
Vasculature was labeled with intravenous injection of either 5% (w/v) tetramethyl-
rhodamine isothiocyanatedextran (TRITC) (T1287, Sigma) for rats, or 5% (w/v)
Texas Red dextran (D1864; Invitrogen) for mice, each dissolved in physiological
saline. We bulk loaded Oregon Green BAPTA (OGB) (06807, Invitrogen) and
sulforhodamine 101 (S7635, Sigma) into the hind paw somatosensory region of
cortex according to protocols described previously [140, 108]. Briefly, OGB (5 µg)
was dissolved in 5 µL solution of 20% pluronic F-127 (P2443, Sigma) in dimethyl
sulfoxide (DMSO) (472301,Sigma), then 40 µL of sulforhodamine 101 (50 µM) in
ACSF was added. The final solution was microinjected ∼300 µm beneath the sur-
face of the brain using a Picospritzer (III, Parker Hannifin Corp.) in three different
locations throughout the hind paw representation. OGB is a calcium-sensitive flu-
orescent dye that labeled all brain cells. Sulforhodamine 101, a red-emitting dye
that labels only astrocytes, allowed neurons and astrocytes to be distinguished
(figure 5.1B) [108].
5.3.3 Peripheral Stimulus
Electrical stimulation was applied via two 25 G needles inserted underneath the
skin of the hind paw contralateral to the imaging region (figure 5.1A). Ten stimula-
tion pulses of 0.5-s duration were applied with an interval of 10 s between successive
stimuli. The stimulus current (∼1 mA) was adjusted to elicit a slight movement
in the toes of the paw. The average response from the 10 stimuli was used in all
analysis.
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5.3.4 In Vivo 2PEF Imaging
In vivo imaging was conducted on a locally-designed 2PEF microscope using an
850-nm, 87-MHz, 100-fs pulse train from a Ti:sapphire laser system (MIRA HP;
Coherent) pumped by a continuous wave laser (Verdi-V18; Coherent) for excita-
tion. Fluorescence emission was collected in two different channels separated by
a 560-nm long-pass dichroic. When imaging rats, emission filters (Chroma, Inc.)
transmitting wavelengths between 485 to 550 nm and 570 to 620 nm were used
to collect green (OGB) and red fluorescence (sulforhodamine 101 and TRITC),
respectively. For mouse imaging, the long wavelength filter was replaced by one
that transmits from 610 to 680 nm to visualize sulforhodamine 101 and Texas Red.
Although imaged on the same fluorescence channel, blood vessels and astrocytes
were easily distinguished based on morphology and location. Laser scanning and
data acquisition was controlled by MPScope software (Nguyen et al., 2006).
To create a map of the cortical vasculature and to localize the regions labeled
by the dye injections, we acquired a stack of images of the entire cranial window
(100 µm depth) using a 0.28 numerical aperture (NA), 4-magnification air objec-
tive (Olympus, Inc.). We changed to a 1.0-NA, 20-magnification water-immersion
objective (Zeiss, Inc.) for high-resolution imaging. We acquired 256 x 256 pixel
frames at a rate of 13 Hz when monitoring calcium transients and 512 x 512 pixel
frames at a rate of 3.3 Hz for image stacks.
After selecting the target vessel to be ruptured (see below), we took a high-
resolution stack of images centered at the hemorrhage site (figure 5.2B and fig-
ure 5.7B). Then we selected between seven and ten non-overlapping 150 µm x 150
µm sites that contained OGB-labeled neurons, located at different distances from
the hemorrhage site and at a depth of 50 to 200 µm beneath the brain surface.
We monitored stimulus-induced calcium transients at each of these locations (fig-
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Figure 5.1: Two-photon imaging of stimulus-induced calcium transients in somatosensory cor-
tex. A. Animals received an electrical stimulus to the hind paw while 2PEF microscopy was used
to monitor changes in neural activity with calcium-sensitive dyes bulk loaded into the cortex.
B. 2PEF image frame taken about 100 µm beneath the cortical surface in a rat. Blood vessels
are labeled red (TRITC), neurons are green (OGB), and astrocytes are yellow (OGB and surl-
forhodamine 101). C. Calcium transients from the neuronal cell body circled in (B). Peripheral
stimulus times are indicated by arrows. D. Average amplitude of the calcium transient across
ten stimuli for the neuronal cell body circled in (B).
ure 5.3). We then induced a hemorrhage in the target vessel and repeated both the
high-resolution image stack (figure 5.2C and figure 5.7B) and the calcium transient
measurements at each site (∼30 minutes after the lesion, figure 5.3). In some rats,
we repeated the measurement of stimulus-induced calcium transients at two and
four hours after the microhemorrhage (figure 5.3). For the chronic experiments
using mice we repeated these measurements one day after the lesion (figure 5.7).
5.3.5 Production of Targeted Microhemorrhages
To induce microhemorrhages, we injured the vessel wall of targeted penetrating ar-
terioles using high intensity laser pulses (∼0.8-µJ, 800-nm, 1-kHz, 50-fs pulse train
from a Ti:sapphire regenerative amplifier (Legend 1k USP; Coherent) pumped by
a Q-switched laser (Evolution 15; Coherent) and seeded by a Ti:sapphire oscilla-
tor (ChinhookTi:sapphire laser; Kapteyn-Murnane Laboratories Inc; pumped by
Verdi-V6; Coherent, Inc)) [110]. We focused these pulses onto the vessel wall of
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penetrating arterioles between 100 and 200 µm beneath the brain surface (fig-
ure 5.2A). To induce a microhemorrhage, we first delivered 1 to 5 bursts of 100
pulses from the 1-kHz pulse train with an initial energy estimated to be below the
threshold for causing vessel rupture (∼100nJ at about 100 m depth)[110]. The
pulse energy was then gradually increased, in 25% increments, until this irradia-
tion lead to sufficient vessel wall damage to cause vessel rupture, allowing blood to
push radially out into the brain (figure 5.2D). The vessel wall clotted within seconds
after rupture, stopping the bleeding. The size of the red blood cell (RBC) filled
hematoma (distinguished by dark cell-sized patches that pushed into the brain and
excluded the blood plasma label) was quantified from image stacks taken within
15 minutes of producing the hemorrhage. In addition, in the mice we quantified
the size of the region where fluorescently-labeled blood plasma penetrated into the
brain. This was more difficult to quantify in rats because the TRITC used to label
the blood plasma in these animals was not bright enough to reliably determine
the limit of blood plasma penetration. One microhemorrhage was induced in each
of fifteen rats and in four mice. In addition, we performed five (three) control
experiments in rats (mice), in which the same imaging was performed but without
the creation of a hemorrhage, as well as three sham experiments in rats, in which
the vessel was targeted using laser pulse energies that were too low to rupture the
vessel.
5.3.6 Analysis of Stimulus Evoked Calcium Transients
We implemented custom scripts in Matlab (The Mathworks, Inc.) that enabled us
to compare the average amplitude of the calcium response of neuronal cell bod-
ies and regions of neuropil at different time points. For each of the imaged sites,
we manually selected neuronal cell bodies and regions of neuropil (∼900 µm2)
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Figure 5.2: Induction of microhemorrhage with femtoseond laser irradiation. A. High energy,
femtosecond laser pulses were tightly focused on the wall of the target vessel to rupture the vessel
and initiate bleeding. B. Projection of 150-µm deep 2PEF image stack of fluorescently-labeled
cortical blood vessels. C. Projection of a 2PEF image stack over the same volume as (B) after
a hemorrhage was produced by rupturing the arteriole in the center of the frame. The RBC-
filled hematoma core (in black) obstructed imaging, and fluorescently-labeled blood plasma was
pushed into the surrounding parenchymal tissue. D. Time course of bleeding after rupturing a
vessel about 100 µm beneath the cortical surface. Fluorescently-labeled blood plasma is red,
while neurons are green and astrocytes yellow.
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that could be identified at all time points before and after the microhemorrhage.
For each stimulus, we calculated the normalized fluorescence change (dF/F o) (fig-
ure 5.1C) over a 4 s window around the stimulus, where F o was taken to be the
mean of the lowest 50% of fluorescence values measured during the 10 s before the
stimulus and dF was the instantaneous fluorescence, averaged across the neuronal
cell body or region of neuropil, minus F o [78]. This definition of F o reduces the
impact of slow changes in fluorescence due to power drifts or movement artifact.
These responses were averaged across all ten stimuli and a moving median filter
(50 samples wide) was applied (figure 5.1D). We calculated the amplitude of the
averaged calcium response for each cell or region at each time point. We excluded
all neuronal cell bodies or regions of neuropil that did not exhibit a stimulus-
evoked response at baseline from further analysis. We computed the ratio of the
post-hemorrhage (or control/sham) response amplitude to the baseline response for
each cell or region. Finally, we classified cells as having a normal post-hemorrhage
response amplitude if this ratio was greater than the mean minus one standard
deviation of the ratios of control and sham data.
Post-mortem Histology
In three mice, we implanted a chronic cranial window [65] and, after one week of
recovery, we triggered three to four microhemorrhages in penetrating arterioles,
separated by at least 1 mm. Three days later animals were transcardially perfused
with phosphate buffered saline (PBS, Sigma-Aldrich) followed by 4% (wt/vol)
paraformaldehyde in PBS. The brain was extracted, soaked in first 30% (wt/vol)
then 60% (wt/vol) sucrose in PBS for 24 hours each. Fiducial marks were placed
with 30 G needle coated with black ink to indicate the edges of the cranial window
and the location of individual microhemorrhages. The tissue was frozen and cut
in 20-µm thick sections on a cryostat. Tissue sections were placed on Permafrost
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Figure 5.3: Changes in somatosensory calcium responses in neuronal cell bodies and regions
of neuropil after a microhemorrhage. A. 2PEF images of cortex (120 µm beneath brain surface;
same labeling as figure 1B) before and over time after a microhemorrhage. The arrow in the
second panel indicates the direction to the microhemorrhage, located 200 µm away. B. Images
from a control experiment. C. Stimulus-induced calcium responses from two neuronal cell bodies
and one region of neuropil (indicated by color coded regions in (A)) before and over time after a
microhemorrhage. D. Calcium responses from a control experiment.
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slides (Superfrost Plus, Fisher Sci.), rehydrated with PBS, and stained with di-
aminobenzidine (DAB) (peroxidise substrate kit, SK-4100, Vector Labs, Inc.) to
label red blood cells. To identify possible apoptotic cells, terminal deoxynucleotidyl
transferase dUTP nick end labeling (TUNEL) was completed (11684795910, Roche
Applied Scientific, Inc.). Briefly, sections were permeabilized in a 0.1% (wt/vol)
Triton X-100, 0.1% (wt/vol) sodium citrate solution in a 4◦C refrigerator for 5
min., then washed in PBS twice for 2 min. each, and treated with the TUNEL
enzyme/labeling solution. The tissue sections were covered with aluminum foil
to exclude light and incubated at 37◦C for 3 hours. Sections were then rinsed in
PBS twice for 3 min. each and imaged with an epifluorescence microscope. We
checked for TUNEL-positive cells in sections that contained a microhemorrhage,
as identified both by the location relative to the fiducial marks and the presence
of DAB-positive red blood cells in the tissue.
Statistical Analysis
Moving medians of post-hemorrhage response amplitudes and the 95% confidence
interval was obtained as a function of distance from the microhemorrhage using
a moving window size of 35 and 45 samples for neuronal cell bodies (figure 5.4A)
and regions of neuropil (figure 5.4C), respectively (1/10th of the total number of
data points). The plots were further smoothed using a 20 sample moving average.
Boxplots containing both control and sham data were produced for neurons (fig-
ure 5.4B) and neuropil (figure 5.4D), respectively. The edges of the box represent
the first and third quartile of data, the red line across the box indicates the median
and the whiskers extend to the maximum and minimum amplitude values that are
not outliers. Individual data points are shown in green for control and in yellow
for sham experiments (figure 5.4B and figure 5.4D).
Bar plots were used to compare the average post-hemorrhage response am-
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plitude ratios at different times after the lesion and at different distances from
the microhemorrhage (figure 5.5 and figure 5.7). Error bars represent the stan-
dard errors of mean. For these data, distributions were found to be non-normal
(Shapiro-Wilk W test), so we used rank-based statistical analysis. We performed
Wilcoxon signed-rank tests to determine if the response amplitude ratios were less
than one.
5.4 Results
We investigated the response of somatosensory neuronal cell bodies and regions
of neuropil to a peripheral stimulus using 2PEF imaging of calcium sensitive dyes
(figure 5.1) before and after femtosecond laser-induced hemorrhage of a nearby
microvessel (figure 5.2). The microhemorrhage consisted of a RBC-filled hematoma
core of about 100 +/− 40 µm (mean +/− standard deviation) diameter, on average
(18 hemorrhages in 18 rats; 19 hemorrhages in 10 mice). Surrounding this core
was a 280 +/− 110 µm diameter region where fluorescently-labeled blood plasma
pushed into the brain parenchyma (figure 5.2; 18 hemorrhages in 9 mice). The
targeted vessel was observed to be flowing after each hemorrhage. We characterized
the changes in stimulus-evoked neural activity as a function of distance from the
microhemorrhage and as a function of time after the lesion (figure 5.3), up to one
day later.
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neuron
Figure 5.4: Post-hemorrhage neural response as a function of distance from the hematoma. A.
Amplitude of the stimulus-induced calcium responses for neuronal cell bodies within 30 minutes
after a microhemorrhage, expressed as a fraction of the baseline responses, for cells at different
distances from the hematoma core. Grey points represent measurements from individual neuronal
cell bodies, while the red line indicates a moving median of the response amplitude. The blue
line represents the fraction of neuronal cell bodies that continued to respond normally to the
peripheral stimulus after the microhemorrhage (i.e. with a response amplitude ratio that was
greater than the mean minus one standard deviation of the amplitude ratio for control and sham
data). The red and blue shaded regions represent 95% confidence intervals about the median
response amplitude and fraction of cells normally responding, respectively. Distance is defined
as the three-dimensional path from the edge of the spherical RBC-filled hematoma core to the
center of the neuronal cell body (inset). B. Box plot of the amplitude of the calcium response
from neuronal cell bodies, expressed as a fraction of the baseline response, for control and sham
experiments. The measurements from individual cells are indicated with green (control) and
orange (sham) circles. C. Amplitude of the stimulus-induced calcium responses for regions of
neuropil within 30 minutes after a microhemorrhage, expressed as a fraction of the baseline
responses, for regions at different distances from the hematoma core. D. Box plot of the amplitude
of the calcium response from regions of neuropil, expressed as a fraction of the baseline response,
for control and sham experiments.
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5.4.1 Average Response Amplitude to a Peripheral Stimu-
lus Decreased Immediately After a Microhemorrhage
in Nearby Areas.
We found that within 30 minutes after a microhemorrhage in the acute rat prepa-
ration, the amplitude of the neural response either disappeared or decreased in
most of the neuronal cell bodies and regions of neuropil located within 150 µm of
the edge of the RBC-filled core of the microhemorrhage (figure 5.3 and figure 5.4).
In this region, the average ratio of the response amplitude to the baseline response
was 0.6 +/- 0.5 (mean +/- standard deviation) and 0.6 +/- 0.6 for neuronal cell
bodies (figure 5.4A) and regions of neuropil (figure 5.4C), respectively. Both con-
trol and sham experiments showed no decrease in the average response amplitude
of neuronal cell bodies (figure 5.4B) and regions of neuropil (figure 5.4D). Further
from the microhemorrhage the immediate impact of the lesion on stimulus-evoked
response amplitude was more modest, with only a minor decrease in activity from
150 to 300 µm from the RBC-filled hemorrhage core and no decrease in activity
further than 300 µm (figure 5.4A and figure 5.4C). Further, we determined the
fraction of neuronal cell bodies and regions of neuropil with a stimulus-evoked
response amplitude that was similar to the response amplitude in controls (i.e.
the post-hemorrhage response was greater than one standard deviation below the
mean response in controls). We found that the fraction of neuronal cell bodies and
regions of neuropil with normal response amplitude was lowest near the microhe-
morrhage and recovered with distance from the microhemorrhage with a similar
trend to the post-hemorrhage response amplitudes (figure 5.4A and figure 5.4C).
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Figure 5, Cianchetti et al. 2011
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Figure 5.5: Changes in average neuronal response over hours after a microhemorrhage. A.
Average of the post-hemorrhage stimulus-induced calcium response amplitudes, expressed as a
fraction of the baseline response amplitudes, for neuronal cell bodies at 0.5, 2, and 4 hours
after a microhemorrhage and for cells located either within 150 µm (light grey) or between 150
and 300 µm (dark grey) of the RBC-filled hematoma, as indicated in the inset. Error bars
represent the standard error of the mean. Dashed line indicates a response amplitude after
the microhemorrhage that is equal to the baseline response. B. Average response for regions
of neuropil. Levels of significance for differences of the average amplitude ratios from one are
indicated by: * p < 0.05, ** p < 0.01, p < 0.001, p < 0.0001 (Wilcoxon signed-rank test).
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5.4.2 The Response to a Peripheral Stimulus Recovered
Toward Baseline with Time After the Microhemor-
rhage
Over time, we observed a distance-dependent recovery of function in the neuronal
cell bodies and regions of neuropil that showed a decreased response immediately
after the microhemorrhage. In acute rat experiments, the response amplitude
recovered to baseline values by four hours after the microhemorrhage at distances
of 150 and 300 µm from the edge of the RBC-filled hematoma. In contrast, activity
remained depressed within 150 µm (figure 5.5). Longer duration acute experiments
were impractical due to the inability to maintain stable physiology during extended
anesthesia.
To investigate whether or not neural response within 150 µm from microhe-
morrhage recovers over a longer time, we developed a chronic mouse preparation
that enabled opening of the craniotomy for re-injection of calcium-sensitive dye
(figure 5.6A). Using this preparation, we characterized stimulus-evoked calcium
transients 24 hours after a microhemorrhage (figure 5.6B-D). Because of differ-
ences in the dye injection and the inclination of the imaging plane, we were able to
successfully identify about 66% (62%) of the same neuronal cell bodies (astrocytes)
one day after the microhemorrhage. Similarly, in control experiments we were able
to identify 74% (66%) of the neuronal cell bodies (astrocytes) after one day. We
found that responses in neuronal cell bodies and regions of neuropil within 150
µm of the hematoma recover to near baseline levels by 24 hours after the lesion
(figure 5.7).
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5.4.3 Microhemorrhages did not Induced Apoptosis in Nearby
Brain Cells.
One possible explanation for finding only about two-thirds of the cells after the
second calcium dye labeling in the chronic mouse experiments is death of neurons.
To rule this out, we checked for apoptotic cells in the vicinity of the microhemor-
rhage. Across three mice, 12 microhemorrhages were produced in the cortex and
seven of these were successfully identified in tissue sections collected three days
after the lesion (figure 5.8A-B). We found no TUNEL-positive cells near the mi-
crohemorrhages (nor in any other cortical sections) (figure 5.8C and figure 5.8D).
As a positive control, we included a section of mouse intestine with each batch of
TUNEL staining and consistently observed apopototic epithelial cells (figure 5.8C,
inset). In addition, we observed extensive TUNEL-positive cells in the penumbral
region of a photothrombotic stroke [170] (data not shown).
5.5 Discussion
Although the presence of brain microhemorrhages have been correlated with cog-
nitive decline in humans [21, 132], the lack of good animal models of microhemor-
rhage has prevented studies of the impact of these lesions on neural function. Such
experiments are necessary to elucidate the mechanistic links between small brain
bleeds and neurological dysfunction. Here, we used tightly-focused femtosecond
laser pulses to rupture the wall of targeted arterioles located beneath the sur-
face of the brain in rodents to model cortical microhemorrhages [110]. In vivo
nonlinear microscopy was used to study changes in peripheral stimulus-induced
calcium transients in individual neuronal cell bodies and regions of neuropil due
to these microhemorrhages. We showed that neural function is interrupted near
66
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Figure 5.6: Chronic imaging of stimulus-induced calcium transients after a microhemorrhage.
A. Schematic of a re-openable chronic cranial window preparation for mouse. A layer of silicone
coated the skull around the craniotomy, and the glass was glued to the silicone. The window
was reopened by gently detaching the silicone from the skull, enabling reinjection of OGB and
sulforhodamine 101 into the cortex. B. Low- and C. high-magnification 2PEF images of the same
regions of the brain before, immediately after, and one day after inducing a microhemorrhage.
The hematoma is visible in the center of the second and third panels in (B). The arrow in the
second panel of (C) indicates the direction to the microhemorrhage, located 40 µm away. D.
Stimulus-induced calcium responses from the neuronal cell body and region of neuropil indicated
on panel (C) by color coding.
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Figure 5.7: Changes in average neuronal response over one day after a microhemorrhage.
Average of the post-hemorrhage stimulus-induced calcium response amplitudes, expressed as
a fraction of the baseline response amplitudes, at 0.5 and 24 hours after a microhemorrhage
(and for controls at 24 hours) for neuronal cell bodies (light grey) and regions of neuropil (dark
grey) located within 150 µm of the RBC-filled hematoma, as indicated in the inset. Error bars
represent the standard error of the mean. Dashed line indicates a response amplitude after the
microhemorrhage that is equal to the baseline response. Levels of significance for differences of
the average amplitude ratios from one are indicated by: ∗ p < 0.05, ∗∗ p < 0.01, † p < 0.001, ††
p < 0.0001 (Wilcoxon signed-rank test).
the microhemorrhage, but recovers over time after the lesion. Recovery occurred
in a distance-dependent manner, with regions closest to the hematoma taking the
longest to regain function. These studies provide the first insight into the spatial
extent and time course of neural dysfunction (and recovery) after brain microhe-
morrhage.
In the acute experiments in rats, we followed changes in the response of each
individual neuronal cell body and region of neuropil up to four hours after the
microhemorrhage. For the chronic experiments in mice, however, we were only
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able to identify about two-thirds of the same cells on the second day of imaging,
leaving open the possibility that some cells died as a result of the lesion. However,
our data suggest this is unlikely because we were able to identify approximately the
same number of cells on the second day of imaging in control experiments as after
a microhemorrhage. Several factors may contribute to our inability to identify all
of the same cells on the second day of imaging. First, the dye injection locations
varied slightly between days, potentially leading to differences in which cells were
labeled. Second, activated microglia and other inflammatory cells are likely present
in the vicinity of the microhemorrhage one day after the lesion [27, 36, 132] and
these cells may either scavenge the calcium dye or otherwise interfere with the
bulk loading process. Finally, although we consistently identified the same region
of brain tissue, we often found small differences in the inclination of the imaging
plane due to differences in the mouse position in the stereotax between the two
days of imaging. This difference in inclination leads to different cells intersecting
the image plane at the edges of the frame, reducing our ability to find the same cells
on both days. Further, we found no evidence of apoptotic cells in the vicinity of
the microhemorrhage using histology. To give time for cells potentially affected by
the microhemorrhage to progress along the apoptotic pathway and thus register as
TUNEL positive, the staining was conducted at three days after the lesion. Taken
together, this data suggest that the recovery in neural response seen one day after
the microhemorrhage is not due to the death of the lowest-responding neurons and
preservation of less affected ones, but rather that all neurons recover the ability to
respond to a peripheral stimulus within one day after the microhemorrhage.
The impact of bleeding from a brain blood vessel on neural health and function
depends critically on the size of the hematoma that is formed. Large intracerebral
hemorrhages lead to widespread cell death and are associated with high rates of
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mortality and morbidity in patients [8, 121]. This cell death is caused by several
factors, including elevations in intracerebral pressure that could cause direct cell
injury and crush blood vessels causing ischemia [121], excitotoxic damage from
the high levels of glutamate or neurotoxic effects of other blood products, such as
thrombin, that enter the brain parenchyma [11, 77, 121, 161], negative effects of
the inflammation triggered by the hemorrhage [48, 175, 168], and damage from
reactive oxygen species, such as those released by lysed red blood cells a few days
after the lesion [121, 163].
The cognitive impact of the microbleeds identified in MRI imaging in patients
remains controversial, with some studies reporting minimal effects [38, 125], and
others [132, 171, 177] finding an association between microbleeds and cognitive
dysfunction. Microbleeds are a frequent consequence of cerebral amyloid an-
giopathy, and it has been suggested that they may contribute to the cognitive
decline in Alzheimers patients[117, 19, 132, 21]. Additionally, the presence of
brain microbleeds has been associated with more severe cognitive impacts after
head trauma [131]. For these smaller bleeds, many of the mechanisms that lead to
cell injury for large hematomas may not play a significant role. For example, there
is not a significant increase in intracranial pressure. Post-mortem studies of mi-
crobleeds in humans have revealed significant inflammation near the lesion. While
there are limited studies of necrotic or apoptotic cell death after microbleeds, the
current data suggest that cell death is not widespread.
For the smallest hemorrhages, few clinical studies are available. The presence
of microhemorrhages (diameter < 200 µm) is common in advanced Alzheimers
disease patients and is correlated with more severe amyloid pathology [21, 132],
suggesting a potential link between microhemorrhages and cognitive decline. In
patients with CADASIL, there is clear evidence of cognitive dysfunction [89], al-
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Figure 5.8: Postmortem histology of tissue near microhemorrhages. A. Low- and B. high-
magnification widefield images of a tissue section containing a RBC-filled hematoma near the
brain surface. RBCs are stained with DAB. C. Low- and D. high-magnification fluorescence
images for TUNEL labeling in the same tissue section as in (A) and (B). No TUNEL-positive
cells were found. The inset in (C) shows TUNEL-positive epithelial cells from a section of
intestine (same scale bar as show in (A)).
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though multiple different kinds of brain pathologies in addition to microhemor-
rhages, such as lacunar infarcts and diffuse white matter changes, are found in
these patients [27]. For microhemorrhages, there are signs of inflammation near
the lesion, including activation of astrocyte and microglia [165] and invasion of
neutrophils and macrophages [27, 36, 132], but no reports have shown evidence
of cell death, although the there are only limited studies of these small lesions to
date. For these small hemorrhages, it is likely that the amount of blood that enters
the brain is small enough that phagocytotic cells and other mechanisms can clean
the cellular environment before significant injury is caused. The work we present
here suggests that these microhemorrhages do, however, lead to a transient loss of
neural function within a few hundred micrometers from the lesion, but that this
function largely recovers over time.
Most likely, the transient loss of neural function we observed is caused by the
infusion of blood plasma into the intracellular space in the brain. This leads to
changes in ion balances and extracellular messengers and to increases in reactive
oxygen species, all of which may interfere with the ability of neurons to normally
receive synaptic input and fire action potentials. Interestingly, the few hundred
micrometer spatial extent of the most severe disruption of neural function we
observed correlates well with the distance that blood plasma penetrates into the
parenchymal tissue in this microhemorrhage model. The less severe impact and
more rapid recovery of neural function in regions further from the microhemorrhage
is consistent with a gradient in concentration of blood plasma products that cause
dysfunction in the brain tissue.
In this study, we did not investigate the impact of the microhemorrhage on the
few neurons that were immediately adjacent to the target vessel (within ∼50 µm).
These cells were likely displaced by the expanding hematoma or surrounded by
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red blood cells. Measurement of calcium transients from these cells was not easily
achieved and so we cannot rule out the possibility that these cells are permanently
dysfunctional. The lack of apoptotic cells in our histology study, however, suggests
that these cells do not die. We also cannot rule out the possibility that lysis of red
blood cells a few days after the microhemorrahge leads to additional injury that
could compromise neural function later.
The short-term loss of neural function we observed here may not be completely
benign. Neurons with decreased input and firing rates may gain and lose synapses
at an elevated rate due to homeostatic mechanisms that seek to maintain neural
input and firing rate, thereby causing potentially aberrant rewiring of neural cir-
cuits. In addition, these hemorrhages may have a more severe impact on neural
health and function if combined with disease backgrounds such as hypertension,
Alzheimers disease, or if they occur in aged brain. The microhemorrhages we stud-
ied were all in cortex, and these lesions may have a different effect in other brain
locations.
Recent data has suggested that occlusion of single penetrating arterioles (the
same class of vessel that we targeted to produce microhemorrhages) leads to cell
death over a several hundred micrometer region [136]. This data suggests, at a
minimum, that small hemorrhages have a less severe impact than occlusion of the
same class of vessel, implying that clinical management of patients with cardio-
vascular risk factors may benefit from aggressive anticoagulation even with added
risk of bleeding from small vessels.
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CHAPTER 6
THE ANTICIPATORY CONTROL OF MOTION-TO-FORCE
TRANSITIONS WITH THE FINGERTIPS ADAPTS OPTIMALLY
TO TASK DIFFICULTY
The data on this chapter was originally published in the following manuscript:
Flor A. Cianchetti, Francisco J. Valero-Cuevas. Anticipatory control of motion-
to-force transitions with the fingertips adapts optimally to task diffi-
culty. Journal of Neurophysiology 2010. 103(1):108-16.
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6.1 Abstract
Moving our fingertips towards objects to produce well-directed forces immediately
upon contact is fundamental to dexterous manipulation. This apparently simple
motion-to-force transition in fact involves a time-critical, predictive switch in con-
trol strategy [156, 157]. Given that dexterous manipulation must accommodate
multiple mechanical conditions, we investigated whether and how this transition
adapts to task difficulty. Eight adults (19 to 39 years old) produced ramps of
isometric vertical fingertip force against a rigid surface immediately following a
tapping motion. By changing target surface friction and size we defined an eas-
ier (sandpaper, 11 mm in diameter) vs. a more difficult (polished steel, 5 mm in
diameter) task. As in prior work, we assembled fine-wire electromyograms from
all seven muscles of the index finger into a 7-dimensional vector defining the full
muscle coordination patternand quantified its temporal evolution as its alignment
with a reference coordination pattern vector for steady-state force production. As
predicted by numerical optimizations to neuromuscular delays [157], our empirical
and sigmoidal nonlinear regression analyses show that the coordination pattern
transitions begin sooner for the more difficult tasks than for the easier tasks (∼120
ms p < 0.02 and ∼115 ms p< 0.015, respectively); and that the coordination pat-
tern transition in alignment is well represented by a sigmoidal trend (R2 >0.7 in
most cases). Importantly, the force vector following contact had smaller directional
error (p< 0.02) for the more difficult task even though the transition in coordi-
nation pattern was less stereotypical and uniform than for the easier task. These
adaptations of transition strategy to task difficulty are compatible with an opti-
mization to counteract neuromuscular delays and noise to enable this fundamental
element of dexterous manipulation.
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6.2 Introduction
Dexterous manipulation often requires us to rapidly make contact with objects to
produce well-directed fingertip force vectors. For example, quickly grasping small,
round or fragile objects like wine glasses, beads, berries, etc. all involve transi-
tioning abruptly from moving the fingertip towards a rigid surface to producing
a well-directed fingertip force vector against it. From a mechanical perspective
this commonplace task is extremely challenging because the control for accurate
finger motion is incompatible with that for well-directed static force. Several au-
thors (e.g., [64, 156, 172]) have demonstrated that this switch in control strategy is
unavoidably sensitive to time-delays and errors in planning. In biological systems
this control challenge is exacerbated by the inability of the neuromuscular system
to switch control strategies and muscle contractions instantaneously or exactly.
Recently we showed that the human nervous system performs this abrupt switch
in control strategy via an anticipatory, time-critical, and neurally demanding tran-
sition of muscle activations before contact (i.e., from those controlling finger mo-
tion to those controlling fingertip force) [156]. In addition to ruling out a passive
impedance based strategy to mediate the contact with the surface, we found that
the muscle coordination pattern clearly transitions from that for motion to that for
isometric force ca. 65 ms before contact. We then used mathematical modeling and
analysis to reveal a switch in the underlying control strategy. Importantly, time
delays due to muscle activation-contraction dynamics suffice to impose a physical
limit on directional accuracy of the fingertip force vector upon contact.
Subsequent numerical simulations [157] show that an anticipatory transition in
joint torques (analogous to that seen experimentally for muscle activations) is a
necessary control strategy to reach the physical limits of the directional accuracy
of force production upon contact. This anticipatory strategy arises in our deter-
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ministic model as a means to compensate for neuromuscular time-delays, and not
from optimizing for robustness to noise/uncertainties. Importantly, the model also
shows that advancing the onset of the transition in joint torques is an optimal
response to increased task difficulty (e.g., small, round and fragile objects that are
wet vs. dry or rough vs. slippery).
Given the stringent mechanical requirements of the motion-to-force transition,
the delays and noise of the neuromuscular system, and the predicted temporal
modulation with task difficulty, we hypothesized that the nervous system will
adapt the onset of the transition of muscle coordination patterns to task difficulty.
We defined the difficulty of the motion-to-force transition by the size and coefficient
of friction of the target surface as either easier (rough-large: a high friction, larger
diameter target) or more difficult (smooth-small: a low friction, smaller diameter
target).
6.3 Methods
The experimental methods are the same as in [156], where the reader can find
complete details. In this abridged description we focus on how we varied the
difficulty of the task by changing the coefficient of friction and size of the target
surface, and on the novel analysis methods.
6.3.1 Experiment
The task consisted of ramping up a fingertip force to a self-selected high mag-
nitude (∼100% MVC) against a flat horizontal target surface after approaching
the surface with a downward motion (figure 6.1A). That is, subjects performed
an abrupt transition from the production of downward motion with their fingertip
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towards the target surface, followed by the production of a large downward static
force. Subjects tapped the horizontal surface of two cylindrical pedestals: smooth
(polished steel) and small (5 mm diameter) vs. rough (360-grit sandpaper) and
large (11 mm diameter). The pedestal was mounted on a 6-axis load cell (model
20E12A-I25, JR3 Inc., Woodland, CA) with a force resolution of 0.01 N. Subjects
wore a custom-molded thermoplastic (MaxD, North Coast Medical, Morgan Hill,
CA) thimble with a spherical, 4.8 mm diameter, Teflon bead embedded on its
distal aspect. This thimble rigorously defined the mechanical task via a unique
contact point and friction cone for force direction [150, 153, 156]. The task was
performed by eight consenting right handed individuals (avg. age 22.8 yrs range
19-39 yrs.) with no history of neurological or hand pathology or injury. They all
read and signed a consent form for this protocol approved by Cornell Universitys
Committee on Human Subjects. Two sessions were run on separate days. In the
first session, the experimental set-up was adjusted to the dimensions of the sub-
jects hand and the subject became acquainted with and practiced the task. In
the second session fingertip force in the three directions and fine-wire EMG were
recorded (2000 samples/s) from all muscles of the index finger while performing
the task. Fine-wire intramuscular electrodes were placed in the seven muscles of
the index finger using previously reported techniques [150, 153, 156]. The muscles
of the index finger are: flexor digitorum profundus (FDP), flexor digitorum super-
ficialis (FDS), extensor indicis proprius (EI), extensor digitorum communis (EC),
first lumbrical (LUM), first dorsal interosseous (DI), and first palmar interosseous
(PI).
Each subject produced three trials per target surface, each of which consisted
of 4 brief, preparatory taps, followed by a tap-ramp-and-hold task (figure 6.1 only
shows the last tap). We instructed the subjects to ramp-up the magnitude of the
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Figure 6.1: Description of experiment. A. Description of the task, following 4 brief preparatory
taps over a specified target, the subject executed a last tap where after making contact with the
target, the subject ramped up the vertical force applied by his finger to a maximum. The figure
shows this last tap. The time of interest was 500 ms before and after contact (red in the time
axis). The subject is wearing a custom thimble during the taps, the thimble allowed a unique
contact point and friction cone for force direction. B. Fingertip force in the three directions was
recorded while performing the task; the figure shows the vertical force magnitude for one trial 500
ms before and after contact. C. Fine-wire EMG from the seven muscles of the index finger was
recorded while performing the task. Normalized weighted EMG is obtained after being filtered,
full-wave rectified, normalized (by MVC), weighted (by physiological cross sectional areas) and
smoothed (50 ms symmetric moving average) the EMG signals. D. The norm weighted EMG
for each of the muscles, constitute a component of the muscle coordination pattern 7D vector
(m(t))The coordination pattern alignment is the angle between the m(t) for each interval of time
(-500 ms to 500 ms) and the m(t) at the time when the vertical force reached its maximum value.
E. The best fit that described the evolution of the coordination pattern alignment during the
transition from motion to force is a sigmoid.
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fingertip force against the surface as quickly as possible, trying the best they could
to keep the finger still and the direction of the force vertical. To enable natural
task performance, we did not provide direct visual feedback of force magnitude or
direction. In our experience and that of others [15] young adults are quite adept at
directing forces perpendicular to the surface even in the absence of direct feedback
about vector direction. Each trial was followed by a mandatory 30 sec rest period
to avoid fatigue. To mitigate learning effects, if any, we randomized the surface
used. After the experiments were over, we reviewed the force and motion plots of
each trial and discarded those where the subjects either slipped while producing
the force; did not produce a uniformly ascending force ramp; or prolonged their last
tap and left less than 450 ms to complete tapping motion. The final data consisted
of 30 trials, 16 using the smooth-small target and 14 using the rough-large target.
6.3.2 Analysis
As in our prior work, we characterized the muscle coordination pattern (m(t))
as the time-varying 7-D unit vector of muscle forces estimated from the filtered
(band-pass 100Hz to 1000 Hz), and then full-wave rectified, normalized (by MVC),
weighted (by physiological cross sectional areas) and smoothed (50 ms symmetric
moving average) EMG signals (figure 6.1C), as in [150, 157]. The temporal evolu-
tion of the coordination pattern vectors for each trial was quantified by the angle
of alignment (θ(t)) of their unit vectors (m(t)) with respect to the unit vector of
the reference coordination pattern (mref ) defined during 80 ms of peak force for
each trial, which occurred roughly 400 ms after contact with the surface [157].
Figure 6.1D shows the evolution of the alignment of one such unit vector from
−500 to +500 ms before and after contact, respectively, for a sample trial. The
onset of force (t=0) was defined at the beginning of the impact spike (figure 6.1B).
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We excluded the first 10 ms of data after the onset of force from our analysis
because unavoidable high-frequency impact transients in the force sensor polluted
the measurement of the force vector magnitude and direction. A perfect alignment
θ(t) =0 means that the relative activations among muscles are the same as mref ,
thus the same muscle coordination pattern is being used at those two time periods.
Likewise, the greater the misalignment θ(t) >0, the greater the differences in the
muscle coordination patterns being used at those two time periods. Figure 6.2
shows a schematic vector representation of the muscle coordination pattern align-
ment during 3 different intervals (before contact, after contact, reference) for a 3
dimensional muscle coordination pattern, i.e., if the system only had 3 muscles.
From the figure it is observed that the angle between the average unit vector during
time interval B and the average unit vector during the reference interval is small
compared with the angle between the average unit vectors in the A and reference
intervals.
We used both non-parametric (i.e., empirical) and parametric (i.e., nonlinear
regression) methods to test for differences in the evolution of coordination pattern
alignment across the two levels of difficulty. In this way we guard ourselves against
the possibility that apparent differences between tasks may simply reflect the fact
that the nonlinear regression is a better model for one dataset than the other. As
we present in the results, we find that the results from both analyses agree. For
the empirical method we plotted the mean subject data, both raw and low-pass
filtered (using a 50 ms symmetrical moving average), as subjects transitioned from
producing motion to producing static force in the two levels of difficulty. The
second method was to perform least-squares fitting to sigmoids, or logistic regres-
sion curves, to the coordination pattern alignment data, θ(t), because sigmoids
are appropriate functions to characterize the general trend for a smooth transition
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Figure 6.2: Vectorial representation of the coordination pattern. A. Normalized weighted EMG
signals from three muscles and its coordination pattern alignment during transition from motion
to force. In gray we emphasize 3 specific times (A, B, reference). B. The coordination pattern
vectors (m(t)) for these 3 specific times (A, B, reference). Measuring the alignment between
vectors (θ(t)) allows us to make quantitative comparisons, the coordination pattern at time A
is further away from the reference than the coordination pattern is at time B. The 3D space is
defined by each of the muscles where the EMG signal was acquired.
between two states. Our prior work shows that the nature of our angle time his-
tories (the motor command as represented by the EMG and its analysis) indeed
reveals a smooth transition between two states [156], figure 6.1D. Note that we
do not mean to imply that the nervous system follows a sigmoidal trend in its
latent command to the exclusion of other possible trends, or that the transition
of the latent command signal is a sigmoid. We do mean, however, that a sigmoid
is an appropriate choice when describing the simple general trend of the motor
command when transitioning between two states.
We used MATLAB (Natick, MA) to fit a sigmoid of the following form to the
θ(t) data: θˆ(t) = a1+ue
−t/τ
1−ve−t/τ u, v > 0
This characterizes the temporal transition of the relative angle between muscle
coordination pattern from -500 ms and +500 ms with respect to the contact time.
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The initial angle θ between the unit vectors m(t) and mref is a
u
v
(i.e., the initial
asymptote early in the finger movement) and is the final angle θ between m(t)
with mref . (i.e., final asymptote reached during steady state static fingertip force
production occurring roughly 400 ms after contact). θˆ(t) is the best fit to the θ(t)
data. After fitting the sigmoid function to each trial, we normalized the sigmoid
functions to have initial and final asymptotes of 1 and 0, allowing us to compare
the trends in the transitions of muscle coordination pattern across subjects, trials,
and levels of difficulty.
We also analyzed the magnitudes of coordination pattern vectors m(t) during
the abrupt transition from motion to force, calculated as the Euclidean norm:
|m(t)| =
√
EMGFDP
2 + EMGFDS
2 + EMGEI
2 + EMGEC
2 + EMGLUM
2 + EMGDI
2 + EMGPI
2
We did not fit sigmoids to these vector magnitude data because they do not
asymptote within the first 500 ms after contact, and thus cannot be represented
as switching between two states.
The accuracy of fingertip force production upon contact was quantified by the
angular deviation of the force vector from the surface normal (φ(t)=0). After low-
pass filtering (80 Hz cut-off, 10th order Butterworth digital filter) the force data,
the angular deviation of the force vector, φ (t), was obtained by the negative arc
tangent of the square root of the squares of the force component parallel to the sen-
sor surface (x and y) divided by the normal component (z); φ(t) = arctan
√
fx2+fy2
|fz |
We performed a 2 way ANOVA test with subject as a random effect to deter-
mine whether task difficulty affects the quality of the fingertip force assessed by
the average φ from 10 ms to 500 ms and φ at 65 ms after contact.
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6.4 Results
As in our prior work [157], transitioning between the production of motion to the
production of force is accompanied by a transition in muscle coordination patterns
(m(t)), as shown by changes in the alignment of the coordination pattern unit vec-
tor, θ(t). Figures 6.3A and B show the changes in alignment and magnitude of the
coordination pattern vectors for one representative trial for both task difficulties.
Figure 6.3A also contains the best-fit sigmoids that model the alignment data.
Figure 6.3C-D show the alignment and magnitude after the data from figure 6.3A-
B was normalized and smoothed by a 50 ms wide moving average. Normalization
was done in each trial by making the mean of the first and last 200 ms be initial
and final values. The normalized θ(t) began at one and ended at zero, and the
normalized force magnitudes started at zero and ended at one. Then, we com-
pared across different trials and conditions because the empirical plots had similar
start and final values. Figure 6.4A-B shows the average alignment ±SE and av-
erage magnitude ±SE transitions (after being normalized and smoothed) from all
subjects for each condition.
Figures 6.3 and 6.4 show empirically that the transition of both alignment and
magnitude differs across task difficulty (smooth-small or rough-large conditions).
We see that switching in magnitude and alignment for the small-smooth condition
occurs earlier. For the alignment we found a significant difference in the time of
onset between the two conditions (p=0.02), with an average onset value of -330
ms for the smooth-small case and -210 ms for the rough-large case. However,
interpreting these empirical trends in alignment can be of limited value because
of the naturally high variability of the EMG signals. Fitting a sigmoid to each
of the trials (as in figure 6.3A) is arguably a better descriptor of the transition
because it captures the general trend. Echoing the empirical trends, we see that
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Figure 6.3: Coordination pattern alignment and magnitude of a representative subject. A.
Coordination pattern alignment and their sigmoidal fits during transition from motion to force
where the surface of contact was either smooth-small (dashed-blue) or rough-large (in red). B.
Coordination pattern magnitude during transition from motion to force where the surface of
contact was smooth-small (dashed, blue) or rough-large (in red). C. Same as in A after the
coordination pattern alignment was normalized and smoothed by a moving average of 50 ms.
D. Same as in B after the coordination pattern alignment was normalized and smoothed by a
moving average of 50 ms.
the majority of the sigmoids for the more difficult condition have an early onset,
whereas only 3 sigmoids do so for the easier condition. Figure 6.5 shows the fitted
normalized sigmoids to all alignment trials color-coded by subject: figure 6.5A for
a rough-large surface and figure 6.5B for a smooth-small surface. Figure 6.6 shows
the transition in alignment for both conditions after averaging across trials ±SE.
Averaging the normalized trends for each condition shows that the transition in
muscle coordination pattern alignment for the smooth-small case begins ∼115 ms
earlier than for the rough-large case (figure 6.4A, figure 6.6). We defined the onset
of the transition in coordination pattern alignment when the global mean for all
cases drop 20 % from the normalized value of 1 (see horizontal dashed lines in
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Figure 6.4: Empirical averaged coordination pattern alignment and magnitude. A. Normalized,
smoothed coordination pattern alignment after been averaged across all trials separated by task
difficulty i.e. smooth-small (dashed, blue) and rough-large (red). The threshold of the transition
onset is marked with a horizontal line at 0.8, the coordination pattern for the smooth-small case
starts the transition sooner than the coordination pattern for a rough-large case (-330 vs. -210
ms, respectively). The thinner dashed lines represent the coordination pattern alignment plus or
minus their standard errors for each condition. B. Normalized, smoothed coordination pattern
magnitude after having been averaged across all trials separated by task difficulty i.e. smooth-
small (dashed, blue) and rough-large (in red). The threshold of the transition onset is marked
with a dashed horizontal line at 0.2, the coordination pattern for smooth-small case starts the
transition slightly sooner than the coordination pattern for a rough-large case.
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figure 6.6A and figure 6.4A), although any thresholds greater than 10% show the
same effect. Importantly, the change in muscle coordination pattern alignment is
90 % complete at the time of contact for both conditions. From figure 6.6 we find
that the mean onset of the transition for the smooth-small case was 333 ms and for
the rough-large case was 218 ms before contact. Calculating the onset of the tran-
sition trial by trial basis, and then averaging them for each condition we obtained
mean transition onset values of 273 and 220 ms respectively for smooth-small and
rough-large. After transformation to normality (using log10), an ANOVA test was
performed with subject as a random effect to evaluate if the difference between
transition times of onset was significant for different conditions, we obtained p=
0.015. Without transformation to normality p=0.019 was obtained. Thus both
methods of calculating the onset find that the more difficult case has a statistically
significant earlier onset.
For the transition in coordination pattern magnitude (figure 6.4B) we found
that the smooth-small case begins 30 ms earlier than for the rough-large case. Re-
call that we did not use a regression analysis for the magnitude data. Moreover,
while the sigmoidal function fits closely the trends in the evolution of the alignment
of coordination patterns for both difficulties, the sigmoidal function is nevertheless
better for the easier condition. The average coefficient of determination ± SE for
the least squares fit to the 30 fitted trials was R2= 0.79±0.037. When separating
the data by task difficulty, the sigmoidal model fits the rough-large case signif-
icantly better (average R2 of 0.9±0.02), than the smooth-small case (R2= 0.7±
0.06), p=0.0008. The statistical significance of the average coefficient of determi-
nation was assessed using a 2-way ANOVA test with subject as a random effect.
The data were transformed
(
1√− lnR2
)
to achieve a normal distribution to meet the
assumptions of these parametric statistical tests given that correlation coefficients
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exhibit floor and ceiling effects. Lilliefors tests were used to evaluate normality.
For completeness we report that a p=0.0003 was obtained without transformation
to normality.
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Figure 6.5: Individual fitted sigmoids, color-coded by subject. Normalized best fit sigmoids
for each of the trial, when the surface of contact was: A smooth-small or B rough-large. We find
that the transition for the easier task occurs later than for the more difficult task (except for one
subject).
In a subsequent analysis, we also computed the power spectral density of the
residuals to the sigmoidal fit (to discard the frequency spectrum of the sigmoids and
account only for the variability about the sigmoidal trend). We see clear differences
when we plot the power spectral density (obtained via fft) of the residuals to the
normalized sigmoids (figure 6.7). This shows in a quantitative way that the nature
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of the variability about the sigmoidal trend differs across conditions, suggestive of
more on-line regulation in the case of the more difficult task (see Discussion).
Figure 6.8A shows angular deviation from vertical of the initial fingertip force
vector, φ, from +10 ms to +500 ms after contact. The plot shows the results from
all trials for each condition. A two-way ANOVA test with subject as a random
effect indicated that the angular error φ at +65 ms (figure 6.8B) and the average
φ from 10ms to 500ms were significantly lower for the smooth-small case p=0.02
and p<0.0001 respectively. Lilliefors tests showed it was necessary to transform
the φ data, and we used a log10 transformation. Without transformation the p-
value was <0.001. We chose to analyze φ at +65 ms because it is a conservative
threshold for any corrections of the force vector on the basis of sensory information
at contact (see Discussion).
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Figure 6.6: Normalized sigmoidal trend alignment. The coordination pattern alignment trend
was obtained after having averaged the adjusted sigmoids from all the trials separated by task
difficulty i.e. smooth-small (dashed, blue) and rough-large (red). The threshold of the transition
onset is marked with a horizontal line at 0.8, the coordination pattern for the smooth-small case
starts the transition sooner than the coordination pattern for the rough-large case (-333 vs. -218
ms, respectively). The thinner dashed lines represent the coordination pattern alignment trend
plus or minus their standard errors for each condition.
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6.5 Discussion
A central limitation of the neuromuscular system is its inability to switch be-
tween control strategies instantaneously or exactly due to unavoidable excitation-
contraction dynamics and noise. Therefore, as described previously [156], the
human nervous system implements an anticipatory, time-critical, and neurally de-
manding switch in control strategy to effectively perform the abrupt transition
from the control of motion to the control of fingertip force. In addition, numerical
simulations predicted that tuning the onset of the anticipatory transition to task
difficulty is compatible with an optimal strategy that counteracts neuromuscular
delays to reach the physical boundaries of performance [157]. We now show exper-
imentally that changes in task difficulty change the temporal features of muscle
coordination patterns during motion-to-force transitions with the fingertips. We
characterized the temporal features of these anticipatory strategies in humans, and
show that the adjustments in transition strategy in response to task difficulty are
indeed compatible with that optimal strategy when performing this critical aspect
of dexterous manipulation.
As in our prior work [156, 157], we first briefly discuss the relationships of our
findings to past work on anticipatory motor control, and the limitations of our
approach. Multiple studies have characterized anticipatory control in the limbs
of humans and animals, (i) for smooth motion-force tasks for limbs subject to
contacting (e.g., manipulanda experiments: [134, 84] and non-contacting ( e.g.,
Coriolis force experiments: [84], and references therein ) force fields, (ii) during
abrupt postural perturbations associated with catching [86, 85], and (iii) animal
studies of posture vs. ground-reaction force control [87] or posture vs. movement
control [83]. Our results agree with their findings and conclusions to the extent
that the nervous system can and does effectively anticipate changes in task con-
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straints. In addition, the timing of the onset of anticipatory changes in EMG
of ∼200 ms prior to changes in task constraints is similar to those found previ-
ously [86]. However, our work critically extends their and our prior work by being
the first, to our knowledge, to record complete muscle coordination patterns from
a musculoskeletal system (limb or finger) and full 3D force vectors to investigate
whether and how the nervous system adapts the predictive transition of mus-
cle coordination patterns to the difficulty of the task of switching abruptly from
motion-to-force production. We believe the limitations of our approach do not
challenge the validity of our conclusions. Although the use of a custom-molded
thimble may appear unnatural, its potential drawbacks are outweighed by the
benefits of a well-defined standardized contact condition across subjects (e.g., fin-
gernail length and shape, skin dryness, friction conditions). This has allowed us
to obtain high-fidelity biomechanical recordings that can be well approximated by
and compared to computational models [153, 150, 156, 157]. In addition, the use
of the thimble does approximate precision pinch acquisition of small or slippery
objects. The results here also suggest future studies such as the effect of lengthy
practice/learning on the neural strategy, or the inclusion of specialized populations
such as microsurgeons or pianists.
The first type of adaptation to task difficulty we see is in the temporal ad-
vancement of the transition in coordination pattern vector. The advancement of
the transition onset in the vector alignment, θ(t), of the coordination pattern for
task difficulty is compatible with ideas of optimal control. Using both empirical
and nonlinear regression analyses, we find that the onset of the transition for the
more difficult task occurred sooner than for the easier task. The average onset
value of -330 ms for the smooth-small case for the symmetrical moving average;
and -210 ms for the rough-large compared with similar average onset times of -333
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and -218 ms obtained from the adjusted sigmoids (figures 3, 4 and 6). Therefore,
our results and conclusions regarding the temporal advancement of the transition
do not depend entirely on the assumptions of sigmoids. When analyzing the sig-
moid fits on a subject-by-subject basis (color coded in figure 6.5), we find that the
transition for the easier task occurs later than for the more difficult task (except
for one subject), in support of the reported mean values we present (figure 6.6).
Advancing the onset of the transition can, at the very least, improve performance
in the more difficult case because it allows more time to implement the coordina-
tion pattern for the production of well-directed force against a slippery surface.
More formally, our recent published computational model of motion-to-force tran-
sitions [157] shows that advancing the onset of the transition in joint torques is an
optimal adaptation to increased task difficulty because of the unavoidable latency
of muscle activation-contraction dynamics (∼36 ms [183]). We have also shown
that in this experimental paradigm, muscle activation-contraction dynamics re-
mains a rate-limiting process in transitioning to the muscle coordination pattern
to produce well-directed isometric force upon contact [156]. Therefore, this ad-
vancement of the transition of coordination pattern vector alignment and vector
magnitude can be considered an optimal adaptation to task difficulty.
The fact that the change in coordination pattern vector direction precedes the
change of vector magnitude in all cases is also in agreement with our prior work
where we show that such temporal disparity represents a nonlinear transformation
of the coordination pattern [157]. (A linear transformation would involve simul-
taneous and proportional scaling of both the vector magnitude and direction.)
We recently showed in computational simulations that such nonlinear transforma-
tions are a task-optimal way to compensate for neuromuscular delays and achieve
accuracy of initial force direction [156].
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The second important tuning in response to the difficulty of the task is that
the transition of vector alignment, θ(t), of the coordination pattern for the easier
task was more stereotypical than for the more difficult task, suggesting different
planning and implementation of the neural control strategy (figure 6.7). We use
the term stereotypical to mean that in one case (the easier task) the coordination
pattern more closely follows the general trend of a sigmoid when transitioning be-
tween two states. This greater compatibility with the general trend of a sigmoid
is quantified by the higher coefficients of determination. The high coefficients of
determination for both task difficulties (>0.7 on average) show that the sigmoidal
model fits both cases very well. That is, the change in coordination pattern vec-
tor alignment with time can be explained as the transition between asymptotes
with a single inflexion point. However, the significantly higher average coefficient
of determination for the transitions for the easier task (0.9±0.02 vs. 0.70±0.06)
shows that a sigmoid model is an even better model for the easier task. Con-
versely, the transitions for the more difficult task contain features that cannot be
captured as well by a stereotypical sigmoid function. This significant difference in
the smoothness of the trends in the transition of coordination pattern alignment
strongly suggests that there are differences in the planning and implementation of
the neural control strategy across conditions. Namely, the easier task seems to be
driven predominantly by a more stereotypical feed-forward and predictive motor
command that more closely follows the general trend of a sigmoid; and is remi-
niscent of the kind that is well established in simple reach-to grasp tasks [92] and
references therein ). Conversely, the departure from a simple sigmoid suggests that
the more difficult task is achieved with more adjustments to the motor command.
In the subsequent spectral analysis, we see that the variability about the general
trend of the sigmoid in the case of the more difficult task has significantly more
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power over a greater frequency range. This greater complexity in the transition
of coordination pattern alignment for the more difficult case is strongly indicative
of more intense on-line regulation of the motor command. Given that in the mo-
tion prior to the transitions of coordination pattern alignment covers the 500 ms
before contact, there is sufficient time to allow sensory-driven and internal model
corrections at all sensory and cortical latencies e.g., from visuomotor to efferent-
copy feedback loops [155, 157]; and reference therein) which may be up-regulated
to perform the adjustments we see for the more difficult task. In fact, this is an
additional benefit to advancing the onset of the transition in coordination pattern
alignment for the more difficult case that our computational models did not take
into account. Namely, if on-line corrections are up-regulated in the more difficult
task, then initiating the transition sooner allows more time to complete on-line
corrections in the presence of neuromuscular delays and noise. We have recently
shown that such rich, task-optimal, on-line corrections are not only possible, but
actually present in the control of accurate fingertip forces [152].
The directional accuracy of the fingertip force vector at contact provides a third
line of evidence suggesting different planning and implementations of the neural
control strategy with task difficulty. The misdirection of the fingertip force vector
error at +65 ms (before any corrections in the force vector can be implemented
on the basis of tactile sensory information at contact [17, 72, 33, 74, 71], is signif-
icantly lower for the more difficult task (figure 6.8). That is, a less stereotypical
and less smooth transition of coordination pattern alignment results in a more
accurate initial force direction against the low-friction surface; whereas a more
stereotypical and smoother transition of coordination pattern alignment results in
a less accurate initial force direction against the high-friction surface. In short,
the up-regulation of the sensorimotor corrections of the transition of coordination
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Figure 6.7: Power spectral density of the residuals to the normalized sigmoids. After removing
the general trend of a sigmoid, the alignment of the muscle coordination pattern shows signif-
icantly more power over a greater frequency range for the more difficult task (blue). A. Fast
Fourier transform from 0 to 200 Hz. B. Box plots of average power in bins 25 Hz wide. Non-
parametric comparison of medians ± notches (standard errors) quantifies that the nature of the
variability about the sigmoidal trend differs across conditions for frequencies <100 Hz where
power is non-negligible.
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pattern alignment has the functional consequence of improving the accuracy of the
force task. This idea of on-line corrections resulting in higher EMG variability and
improved performance is compatible with our prior work [152, 151]. We refrain
from commenting further on the details of force production beyond +65 ms after
contact for several reasons. Firstly, the focus of this work is to explore the trends
in muscle coordination during the motion-to-force transition, which saturates and
is 90% complete before contact. Secondly, as stated above, any changes in force
magnitude and direction beyond +65 ms can be attributed to a large number of
possible voluntary and involuntary mechanismsand are thus best studied under
specifically designed conditions as in, for example, [153, 152].
How can we interpret this up-regulation in the context of control theory and
neuromuscular control? We specifically mean that the more difficult task (smooth-
small) displays greater online corrections (i.e., departure from the sigmoidal trend
and variability at higher frequencies) in response to variability and disturbances
arising from the constraints of the task and noise in the nervous system. We ex-
plicitly designed our experiment around two different short-duration tapping tasks,
one with tighter constraints on motion and force accuracy than the other. There-
fore, optimal control theory would require that the nervous system pre-compute
(i.e., learn) control laws and gains tuned to each task (for a review of control theory
in the context of neuromuscular control please see [151]. Importantly, for noisy
systems such as the sensorimotor system, there is a trade-off between accuracy
and sensitivity to noise because tasks that require higher accuracy need to reject
perturbations more aggressively. This is exactly what we see in our results. Per-
forming the task with tighter constraints (i.e., on the final position of the fingertip
and accuracy of the initial fingertip force) will naturally exhibit more variability
than the task with more relaxed constraints because the perturbation-rejection
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Figure 6.8: Deviation of the fingertip force vector after contact. A Deviation angle of force
vector from vertical, φ, from all trials for the two conditions: smooth-small (dashed, blue) and
rough-large (red). The first 10 ms were excluded for all analyses. The force direction appears to
deviate more for the rough-large condition than for the smooth-small condition. B Comparison of
the deviation angle at 65ms after contact between smooth-small and rough-large condition. The
angle of deviation at 65ms is significantly higher for the rough-large than for the smooth-small
condition (p=0.02).
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gains need to be higher. In fact, our results provide new critical evidence at the
level of muscle commands of real consequences of endogenous noise to sensorimotor
control of movement.
Equally importantly, these results showing effective on-line corrections critically
modify the common view that grasp acquisition is universally a memory-driven,
feed-forward phenomenon [92] and references therein). Surely, the predictive na-
ture of grasp acquisition is undeniable as seen by the onset of the transition in
muscle coordination patterns prior to fingertip contactand which in other work is
seen as pre-shaping of the fingertips and predictable grip forces [92]. However, our
results reveal a previously unseen layer of low-level control at the level of mus-
cle coordination: the up-regulation of on-line corrections to the motor command
underlying the predictive trend. These results are compatible with, and add to
the significance of, early reports of kinematic adjustments during rapid finger mo-
tions [16]. The specific mechanisms for these on-line corrections remain unclear,
however, so future work is called for.
This work also allows us to articulate clear paths to improve our understanding
of the neural control of dexterous manipulation. For example, the main features
of this anticipatory strategy can be explained by deterministic models [156, 157]
as an optimal adaptation to neuromuscular time-delays, with no need to consider
optimizing for robustness to noise/uncertainties. However, our findings indicating
greater variability in the motor command for the more difficult task compel us to
consider the extent to which up-regulation of on-line corrections are indeed driven
by a need to establish robustness to noise/uncertainties. In addition, our results
oblige us to develop computational models and experimental paradigms to sys-
tematically interrogate the nervous system to identify the specific sensory and/or
feedback and/or efference copy mechanisms responsible for the context-dependent
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up-regulation of on-line corrections used to improve performanceand more rig-
orously establish whether and how optimality principles apply to the control of
fingertip forces to enable dexterous manipulation. Lastly, future work is needed to
expand the current thinking attributing grasp acquisition to purely feed-forward
processes to establish a context-dependent continuum of control strategies. In
summary, on the basis of our results and our prior work, we conclude that these
three adaptations to task difficulty are all compatible with an optimal strategy
to counteract neuromuscular delays to enable this fundamental feature of dexter-
ous manipulation: making rapid contact with the object to produce well-directed
forces.
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CHAPTER 7
CONCLUSIONS AND FUTURE OUTLOOK
Advances in science have been driven by advances in technology. Nowdays we
are able to use methodologies that were impossible some decades ago. For exam-
ple, the ability to image inside a live brain with micrometer and more recently
nanometer resolution, to record neural activity from multiple cells simultaneously
and to create genetically engineered mice. These and other tools allow us to design
experiments to decode human body function and develope therapies to improve
human health. Using cutting edge technology, this dissertation provides a better
understanding of the brain focusing on immediate effects of microhemorrhages.
We studied small hemorrhages which were induced in the brain arterioles of
rodents using non-linear laser ablation to rupture the wall vessel and 2PEF to
simultaneously visualize the creation of hemorrhage and characterize the region
of injury. The use of animal models allowed for the induction of multiple brain
microhemorrhages and the testing of drugs to reveal pharmacological effects on
hemorrhage size. We investigated the use of Tissue Plasminogen Activator (tPA)
and Dabigatran Etexilate (DE) in cases where patients had or are at risk for devel-
oping hemorrhagic strokes. tPA is the only drug available to dissolve blood clots,
while Dabigatran Etexilate (DE) is a blood thinner which is chronically adminis-
tered to patients to help prevent thrombolytic strokes. Currently, the use of these
drugs is limited by fear of possible hemorrhagic complications, however we found
that neither tPA or DE administered in mice exacerbated brain hemorrhage size.
Mice treated with warfarin or heparin, which are also blood thinners, developed
larger brain hemorrhages. Even though, the negative effects of warfarin and hep-
arin on hemorrhagic strokes have been previously discovered, this was the first time
that their effects on the size of microhemorrhages have been shown. Heparin and
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warfarin were used as positive controls for tPA and DE. The results obtained in the
tPA and DE laser-induced microhemorrhage studies were confirmed using a colla-
genase model by our collaborators. Furthermore, in the case of DE, similar results
were obtained with a clinical trial where fewer patients developed hemorrhages
under DE therapy than patients under warfarin treatment.
These results, therefore, suggest a change in the protocol for treating patients
at risk of stroke with a more generalized used of DE, and the judicious use of
warfarin. This study also suggests that the next step for tPA should be a clinical
trial of immediate administration of tPA to patients with symptoms of ischemic
strokes even before ruling out hemorrhagic stroke. If, as in rodents, tPA does not
have undesired effects on hemorrhages, then tPA would be able to save more lives
when administered promptly.
We also characterized, on a cellular basis, the effects of a microhemorrhage
on neuronal activity using calcium imaging and 2PEF. We compared individual
amplitude responses to an external stimulus on neurons and neuropil before and
after a microhemorrhage was induced on an arteriole. We monitored cells posi-
tioned between the edge of hemorrhage RBC core and 1000 µm away. In addition,
we monitored the same cells at different times with respect to hemorrhage induc-
tion (immediately, 2hrs, 4hrs, 24hrs after). We found that the amplitude of cell
responses with respect their baseline (before hemorrhage) depended on their dis-
tance from hemorrhage and the lapsed time between the hemorrhage induction
and the recording of response. Responses from cells within 150 µm of the hem-
orrhage were notably reduced, with a third of the cells not responding at all. In
contrast, cells that were more than 300 µm away from the hemorrhage presented
an average amplitude similar to control experiments, where we did not induce a
hemorrhage but recorded responses at the same time intervals. Amplitudes of cells
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located between 150 and 300 µm were also decreased, but not to the extent of
proximal cells. Comparing the amplitude of responses obtained at the different
times after hemorrhage, we found that cells eventually recover, with proximal cells
requiring longer to return to baseline response. This recovery occurred at 4hrs for
cells between 150 and 300 µm and 24hrs for cells within 150 µm.
This dissertation shows for the first time the damage caused by a microhemor-
rhage and that it is reversible. Previous work has suggested a link between patients
with microhemorrhages and cognitive dysfunction from clinical studies. Addition-
ally, et. al. Rosidi [127] could not find damage to dendrite structure within a
week of post-microhemorrhage observation. It appears that even though neuronal
morphology is not affected by a microhemorrhage, functionality gets disturbed
temporarily and only in the most proximal region (<300 µm).
To support the claim of non permanent damage to cells after a microhemor-
rhage, we performed TUNEL labeling on brain slices that had previously induced
microhemorrhages to assess apoptosis; results do not show tunnel positive cells
near the microhemorrhage. However a more robust ex-vivo study it is suggested.
Another experiment to further confirm viability of cells in-vivo would be to use
transgenic mouse line that expresses fluorescently labeled interneurons. Interneu-
rons have been shown to be more sensitive to external insults.
Another study should also consider analyzing calcium responses from astrocytes
to find out whether their response to stimulus after a hemorrhage changes or
remains unaffected at all times, as suggested by a fairly constant Sulforhodamine
101 labeling before and after hemorrhage.
Clinically, people usually present microhemorrhages under different conditions
than the ones analyzed in this study, frequently with advanced age. It is possible
that the aged brain would employ longer recovery times or it may not recover
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at all. There are other high risk factors associated with microhemorrhages such
as hypertension, obesity, microangiopathy, etc, that should be included in future
studies. Besides the cerebral cortex, microhemorrhages in humans have been found
in other regions deep in the brain such as basal ganglia, thalamus, brain stem, and
cerebellum. It would be important to investigate whether or not other regions
are more sensitive to the effects of microhemorrhages possibly causing cognitive
decline. Such study is currently beyond modern technology because 2PEF is not
able to access deep brain structures due to scattering of laser light into the tissue.
A more viable study is to induce multiple hemorrhages on cortex separated by
about 300 µm and observe if cells still can recover or whether there is a cumulative
effect.
Comparing amplitude responses on cell by cell basis to study the effects of
microhemorrhage on neuronal function is recommended in studies aiming to detect
very subtle changes. This is only practical after having assessed intact morphology.
This work provides details that may help to improve therapy for ischemic
strokes in the brain and answers main questions on the effects of a single hem-
orrhage on neurons in a healthy brain; it provides future steps that need to be
covered to discern the link between microhemorrhages and cognitive dysfunction.
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.1 Detailed Protocol for Calcium Dye Preparation
.1.1 Reagents
1 vial (50µg) of Oregon Green 488 BAPTA-1, AM (OGB) (06807, Invitrogen)
Artificial cerebrospinal fluid (ACSF) [79]
50µM solution of Sulforhodamine 101 (S7635, Sigma) in ACSF
Pluronic F-127 (P2443, Sigma)
Dimethyl Sulfoxide (DMSO) (472301, Sigma)
.1.2 Procedure
1. Dissolve 1 g of Pluronic F-127 in 5 ml of DMSO to make a 20% solution.
Notes: The solution dissolves slowly, it can be left overnight on a moving platform,
or warmed up prior to mixing for 30min or until the Pluronic F-127 is completely
dissolved.
2. Sterilize ∼0.5 ml of the Pluronic-DMSO solution, ∼0.5 ml of the sulforhodamine
101 solution and ∼0.5 ml of ACSF by passing each through a syringe-driven filter
(SLGP033RS, Millipore). Place each of the solutions in sterile eppendrof tubes.
Notes: The 20% Pluronic-DMSO solution can be stored at 5◦C and should be used
within 3 days. The Sulforhodamine 101 solution can be stored at −20◦C .
3. Ensure that all OGB is on the bottom of the vial by lightly tapping on it. Add
5 µl to the vial and centrifuge for at least 15 min or until pale yellow.
4. Add 25 µl each of the sterile sulforhodamine 101 and ACSF solutions to the
vial, and centrifuge for 15 min.
Notes: The concentration of the sulforhodamine 101 solution in ACSF(∼50 µM)
can be roughly adjusted depending of its brightness during imaging.
5. Tightly close the vial and cover it completely with parafilm (01852, SPI).
105
6. Place the vial on a vortexer for 10 min.
Notes: Use parafilm or tape to attach the vial to the vortexer if necessary.
7. Submerge vial inside a sonicator filled with water. Turn it on for 30 minutes.
8. Remove vial from sonicator, dry and remove parafilm.
9. Place the vial in centrifuge for 5 min to remove bubbles.
10. Cover it with aluminum foil and use immediately.
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